Rede D'Or Sao Luiz SABMFBOVESPA: RDOR3

Financial Statements 3Q26

· Issued by Rede D'Or Sao Luiz SA
Interim financial information Rede D'Or São Luiz S.A.

September 30, 2026

with Independent Auditor's Review Report

Rede D'Or São Luiz S.A. Interim financial information September 30, 2026

Contents

Independent auditor's review report on interim financial information 1

Interim financial information

Statements of financial position 3

Statements of profit or loss 5

Statements of comprehensive income 6

Statements of changes in equity 7

Statements of cash flows 8

Statements of value added 9

Notes to the interim financial information 10

Centro Empresarial PB 370

Praia de Botafogo, 370

8º ao 10º andar - Botafogo

22250-040 - Rio de Janeiro - RJ - Brazil Phone: +55 21 3263-7000

ey.com.br

Independent auditor's review report on interim financial information

To the Shareholders, Board of Directors and Officers of

Rede D'Or São Luiz S.A.

Rio de Janeiro - RJ, Brazil

Introduction

We have reviewed the accompanying individual and consolidated interim financial information contained in the Quarterly Information Form (ITR) of Rede D'Or São Luiz S.A. (the "Company") for the quarter ended September 30, 2026, which comprises the statement of financial position as of September 30, 2026, and the related statements of profit or loss and of comprehensive income for the three and nine-month periods then ended, and of changes in equity and of cash flows for the nine-month period then ended, including the explanatory notes.

The executive board is responsible for the preparation of the individual and consolidated interim financial information in accordance with Accounting Pronouncement CPC 21 (R1) - Interim Financial Reporting, and with IAS 34 - Interim Financial Reporting (IFRS Accounting Standards), issued by the International Accounting Standards Board (IASB), as well as for the fair presentation of this information in accordance with the rules issued by the Brazilian Securities and Exchange Commission (CVM) applicable to the preparation of the Quarterly Information Form (ITR). Our responsibility is to express a conclusion on this interim financial information based on our review.

Scope of review

We conducted our review in accordance with Brazilian and international standards on review engagements (NBC TR 2410 and ISRE 2410 Review of Interim Financial Information Performed by

the Independent Auditor of the Entity, respectively). A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with auditing standards and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion on the individual and consolidated interim financial information

Based on our review, nothing has come to our attention that causes us to believe that the accompanying individual and consolidated interim financial information included in the quarterly information referred to above is not prepared, in all material respects, in accordance with Accounting Pronouncement CPC 21 (R1) and IAS 34 applicable to the preparation of Quarterly Information Form (ITR), and presented consistently with the rules issued by the Brazilian Securities and Exchange Commission (CVM).

1

A member firm of Ernst & Young Global Limited

Other matters - Statements of value added

The abovementioned quarterly information includes the individual and consolidated statements of value added (SVA) for the nine-month period ended September 30, 2026, prepared under the responsibility of the Company's executive board and presented as supplementary information under IAS 34. These statements have been subject to the same review procedures performed together with quarterly information review, in order to conclude whether they have been reconciled to the interim financial information and accounting records, as applicable, and whether their form and content are in accordance the criteria defined in Accounting Pronouncement CPC 09 - Statement of Value Added.

Based on our review, nothing has come to our attention that causes us to believe that these statements of value added were not prepared, in all material respects, in accordance with the criteria set forth by this standard and consistently with the individual and consolidated interim financial information as a whole.

Rio de Janeiro, November 11, 2026. ERNST & YOUNG

Auditores Independentes S/S Ltda. CRC SP-015199/F

Wilson J.O. Moraes Accountant CRC RJ-107211/O

Assets Current assets

Cash and cash equivalents

4

728,396

214,163

3,209,997

3,705,415

Securities

4

8,766,492

8,410,483

39,447,148

36,855,083

Accounts receivable

5

5,402,603

5,312,008

10,511,349

10,167,395

Inventories

6

582,782

527,778

1,276,035

1,196,110

Taxes recoverable

930,761

541,680

1,765,844

948,238

Insurance contract assets

12

-

-

-

27,999

Reinsurance contract assets

-

-

51,016

41,012

Derivative financial instruments

24

73,406

69,545

116,865

92,345

Transactions with related parties

7

1,596,700

1,775,289

-

-

Dividends receivable

248,441

492,527

10,920

-

Other

468,080

397,550

916,485

745,273

Total current assets

18,797,661

17,741,023

57,305,659

53,778,870

Noncurrent assets

Transactions with related parties

7

4,040,811

3,631,865

54,614

74,154

Securities

4

399,115

-

4,629,202

1,775,096

Accounts receivable

5

-

-

1,782,470

1,734,724

Taxes recoverable

8,677

8,677

542,136

503,368

Insurance contract assets

12

-

-

-

21,342

Reinsurance contract assets

-

-

13,163

12,565

Judicial deposits

14

489,561

482,842

2,934,791

2,652,869

Deferred taxes

17

647,902

374,569

4,098,179

4,327,326

Derivative financial instruments

24

579,419

417,886

2,471,358

2,954,497

Investments in subsidiaries, associates and joint

ventures

8

35,026,605

31,468,248

2,482,421

2,437,864

Property and equipment

9

6,689,848

6,215,239

18,201,057

16,789,930

Intangible assets

10

7,509,364

7,563,708

15,697,457

15,809,019

Right of use - leases

11

2,431,582

2,566,017

3,239,481

3,102,204

Other

272,267

325,010

538,951

574,704

Total noncurrent assets

58,095,151

53,054,061

56,685,280

52,769,662

Total assets 76,892,812 70,795,084 113,990,939 106,548,532

Liabilities and equity Current liabilities

Trade accounts payable

831,270

803,791

1,950,266

1,761,444

Derivative financial instruments

24

733,214

637,183

1,216,579

1,083,440

Loans, financing and debentures

13

4,923,161

1,745,424

4,779,237

1,712,740

Transactions with related parties

7

-

-

-

16,860

Salaries, accruals and social charges

625,481

628,170

1,431,213

1,248,171

Tax obligations

381,781

280,726

1,225,592

924,479

Accounts payable for acquisitions

17,237

15,668

519,683

475,207

Dividends and IOE payable

16

2,457,269

3,023,466

2,494,811

3,060,098

Insurance contract liabilities

12

-

-

7,928,885

6,904,651

Leases

15

639,130

616,902

827,084

760,520

Other

95,445

69,134

1,212,199

1,324,999

Total current liabilities

10,703,988

7,820,464

23,585,549

19,272,609

Noncurrent liabilities

Derivative financial instruments

24

939,897

1,004,181

1,260,741

1,045,045

Loans, financing and debentures

13

39,303,192

38,139,109

44,881,499

44,521,391

Transactions with related parties

7

8,984

-

5,422

4,337

Tax obligations

25,211

26,610

126,576

130,237

Accounts payable for acquisitions

50

338

209,365

215,617

Insurance contract liabilities

12

-

-

11,945,860

11,789,166

Deferred taxes

17

-

-

492,077

385,699

Provision for contingencies

14

538,679

530,315

3,540,525

3,092,700

Provision for losses on investments

8

930,035

839,321

-

-

Leases

15

2,368,507

2,493,811

3,119,010

2,963,924

Other

728,294

589,227

1,157,507

1,506,720

Total noncurrent liabilities

44,842,849

43,622,912

66,738,582

65,654,836

Equity Capital

16

15,711,360

15,711,360

15,711,360

15,711,360

Share issue costs

(253,031)

(253,031)

(253,031)

(253,031)

Capital reserves

4,610,636

5,009,707

4,610,636

5,009,707

Treasury shares

(1,823,119)

(1,828,733)

(1,823,119)

(1,828,733)

Income reserves

146,337

146,337

146,337

146,337

Retained earnings

2,302,752

-

2,302,752

-

Advance for future capital increase

4,224

4,224

4,224

4,224

Other comprehensive income

646,816

561,844

646,816

561,844

Total equity attributable to the Company's shareholders

21,345,975

19,351,708

21,345,975

19,351,708

Noncontrolling interests

-

-

2,320,833

2,269,379

Total equity

21,345,975

19,351,708

23,666,808

21,621,087

Total liabilities and equity

76,892,812

70,795,084

113,990,939

106,548,532

See accompanying notes.

Statements of profit or loss

Three and Nine-month periods ended September 30, 2026 and 2025 (In thousands of Brazilian reais, unless otherwise stated)

Individual

Consolidated

07/01/2026 to

01/01/2026 to

07/01/2025 to

01/01/2025 to

07/01/2026 to

01/01/2026 to

07/01/2025 to

01/01/2025 to

Note

09/30/2026

09/30/2026

09/30/2025

09/30/2025

09/30/2026

09/30/2026

09/30/2025

09/30/2025

Operating revenue, net

18

4,430,830

12,869,233

4,042,533

11,710,778

15,242,042

44,242,408

14,415,537

41,349,416

Operating costs

19

(2,902,654)

(8,578,583)

(2,753,824)

(7,952,990)

(11,089,892)

(33,305,091)

(11,054,613)

(32,355,128)

Gross profit

1,528,176

4,290,650

1,288,709

3,757,788

4,152,150

10,937,317

3,360,924

8,994,288

General and administrative expenses

20

(381,185)

(1,096,633)

(230,847)

(838,443)

(744,096)

(2,078,208)

(532,955)

(1,588,063)

Selling expenses

(10,604)

(30,112)

(19,813)

(5,137)

(21,764)

(66,137)

(49,689)

(33,830)

Equity accounting

8

1,360,201

3,417,094

1,403,292

3,238,463

14,571

27,799

16,301

28,799

Other operating income (expens es), net

21

(62,887)

186,237

(57,359)

(66,386)

(283,638)

(102,879)

(46,170)

(174,988)

Income before finance income (costs) and income and social contribution taxes

2,433,701

6,767,236

2,383,982

6,086,285

3,117,223

8,717,892

2,748,411

7,226,206

Finance income

22

1,352,861

3,924,824

630,009

2,423,503

2,949,384

9,594,228

2,694,595

8,191,258

Finance costs

22

(2,473,084)

(7,497,602)

(1,714,295)

(5,434,678)

(4,352,956)

(13,491,000)

(3,543,986)

(10,974,178)

Profit before income taxes

1,313,478

3,194,458

1,299,696

3,075,110

1,713,651

4,821,120

1,899,020

4,443,286

Income taxes

17

(36,996)

258,294

174,197

440,864

(347,000)

(1,156,433)

(360,893)

(790,620)

Profit for the period

1,276,482

3,452,752

1,473,893

3,515,974

1,366,651

3,664,687

1,538,127

3,652,666

Profit attributable to controlling interests

1,276,482

3,452,752

1,473,893

3,515,974

1,276,482

3,452,752

1,473,893

3,515,974

Profit attributable to noncontrolling interests

-

-

-

-

90,169

211,935

64,234

136,692

Basic earnings per share (in reais)

23

0.5910

1.5892

0.6679

1.5933

0.5910

1.5892

0.6679

1.5933

Diluted earnings per share (in reais)

23

0.5910

1.5892

0.6679

1.5933

0.5910

1.5892

0.6679

1.5933

See accompanying notes.

Statements of comprehensive income

Three and Nine-month periods ended September 30, 2026 and 2025 (In thousands of Brazilian reais)

Individual

Consolidated

07/01/2026 to 01/01/2026 to

07/01/2025 to

01/01/2025 to

07/01/2026 to

01/01/2026 to 07/01/2025 to

01/01/2025 to

09/30/2026 09/30/2026

09/30/2025

09/30/2025

09/30/2026

09/30/2026 09/30/2025

09/30/2025

Profit for the period 1,276,482 3,452,752

1,473,893

3,515,974

1,366,651

3,664,687 1,538,127

3,652,666

Other comprehensive income Cash flow hedge

(22,146)

(38,695)

(14,877)

(105,469)

(39,835)

(38,907)

(20,702)

(130,566)

Gain/loss on insurance and reinsurance liabilities

-

-

-

-

(190,653)

155,857

52,081

(213,780)

Unrealized gains (losses) on financial assets at fair value through OCI

-

-

-

-

153,671

32,665

(41,100)

9,100

Tax effects

7,530

13,156

5,059

35,859

28,811

(64,643)

(2,408)

122,901

Gains (losses) on changes in equity interest

-

-

-

-

-

-

34,417

-

Other comprehensive income of associates and

subsidiaries under the equity method

(33,390)

110,511

32,106

(142,735)

-

-

-

-

(48,006)

84,972

22,288

(212,345)

(48,006)

84,972

22,288

(212,345)

Total comprehensive income 1,228,476

3,537,724

1,496,181

3,303,629

1,318,645

3,749,659

1,560,415

3,440,321

Attributable to: Controlling interests

1,228,476

3,537,724

1,496,181

3,303,629

1,228,476

3,537,724

1,496,181

3,303,629

Noncontrolling interests

-

-

-

-

90,169

211,935

64,234

136,692

See accompanying notes.

Statements of changes in equity

Nine-month periods ended September 30, 2026 and 2025 (In thousands of Brazilian reais)

Attributable to the Company's controlling shareholders

Description

Capital

Premium reserve

Share issue (share cos ts issue)

Premium on capital

transactions

Share-based payment

reserve

Treasury s hares

Legal reserve

Investment reserve

Other

comprehensiv e income

Advance for future capital increase

Retained earnings

Total equity

Noncontrolling interests

Total

Balances at December 31, 2024

15,711,360

(253,031) 6,190,053

(1,229,297)

-

1,458,602)

8,666

4,921,769

807,485

4,224

- 24,702,627

1,999,241

26,701,868

Capital transactions in subsidiaries and acquisition of

noncontrolling interests -

-

-

31,775

-

-

-

-

-

-

-

31,775

537,040

568,815

Changes - RSU (Note 16) -

-

14,427

-

(14,198)

802

-

-

-

-

-

1,031

-

1,031

Share-based payment (Note 16) -

-

-

-

14,198

-

-

-

-

-

-

14,198

-

14,198

Profit for the period -

-

-

-

-

-

-

-

-

-

3,515,974

3,515,974

136,692

3,652,666

Dividends and interest on equity (Note 16) -

-

-

-

-

-

-

(1,350,000)

-

-

-

(1,350,000)

(203,032)

(1,553,032)

Share buyback -

-

-

-

-

(370,933)

-

-

-

-

-

(370,933)

-

(370,933)

Cash flow hedge (Note 16) -

-

-

-

-

-

-

-

(69,610)

-

-

(69,610)

-

(69,610)

Equity adjustments -

-

-

-

-

-

-

-

(14,454)

-

-

(14,454)

-

(14,454)

reinsurance contracts -

-

-

-

-

-

-

-

(128,281)

-

-

(128,281)

-

(128,281)

Balances at September 30, 2025 15,711,360

(253,031)

6,204,480

(1,197,522)

-

(1,828,733)

8,666

3,571,769

595,140

4,224

3,515,974

26,332,327

2,469,941

28,802,268

Balances at December 31, 2025 15,711,360

(253,031)

6,215,354

(1,205,647)

-

(1,828,733)

8,666

137,671

561,844

4,224

-

19,351,708

2,269,379

21,621,087

Capital transactions in subsidiaries and acquisition of

noncontrolling interests -

-

-

786,192

-

-

-

-

-

-

-

786,192

(140,775)

645,417

Changes - RSU (Note 16) -

-

2,546

-

-

-

-

-

-

-

-

2,546

-

2,546

Profit for the period -

-

-

-

-

-

-

-

-

-

3,452,752

3,452,752

211,935

3,664,687

Dividends and interest on equity (Note 16) -

-

-

-

-

-

-

-

-

-

(1,150,000)

(1,150,000)

(19,706)

(1,169,706)

Share buyback -

-

-

-

-

(1,182,195)

-

-

-

-

-

(1,182,195)

-

(1,182,195)

Cancellation of shares (Note 16.c) -

-

(1,187,809)

-

-

1,187,809

-

-

-

-

-

-

-

-

Cash flow hedge (Note 16) -

-

-

-

-

-

-

-

(25,666)

-

-

(25,666)

-

(25,666)

Equity adjustments -

-

-

-

-

-

-

-

17,092

-

-

17,092

-

17,092

reinsurance contracts -

-

-

-

-

-

-

-

93,546

-

-

93,546

-

93,546

Capital Capital reserves Income reserves

Net finance income (costs) from insurance and

Net finance income (costs) from insurance and

Balances at September 30, 2026 15,711,360 (253,031) 5,030,091 (419,455) - (1,823,119) 8,666 137,671 646,816 4,224 2,302,752 21,345,975 2,320,833 23,666,808

See accompanying notes.

Statements of cash flows

Nine-month periods ended September 30, 2026 and 2025 (In thousands of Brazilian reais)

Individual Consolidated

09/30/2026

09/30/2025

09/30/2026

09/30/2025

Cash flows from operating activities

Profit before income and social contribution taxes 3,194,458

3,075,110

4,821,120

4,443,286

Adjustments to reconcile profit before taxes to cash flows from operating activities

Depreciation and amortization

666,809

717,334

1,352,870

1,404,681

Gain on disposal of properties

(2,940)

(2,940)

(2,940)

(2,940)

Fair value of debt

29,509

603,463

(420,340)

740,136

Interest, monetary and foreign exchange differences, net

3,916,499

2,620,375

1,681,330

(427,586)

Share-based payment

77,118

68,195

77,118

68,195

Provision (reversal) for contingencies

20,914

(111,342)

600,268

249,927

Equity accounting

(3,417,094)

(3,238,463)

(27,799)

(28,799)

Income (loss) from insurance service

-

-

(8,864,333)

(6,924,900)

Allowance for expected credit losses

638,078

576,884

1,260,746

1,094,642

(Increase) decrease in assets and increase (decrease) in liabilities

Accounts receivable

(818,706)

(1,237,107)

(1,652,446)

(2,000,065)

Inventories

(61,184)

(30,988)

(112,863)

10,229

Taxes recoverable

(286,266)

83,402

(820,565)

(23,336)

Judicial deposits

(6,817)

(36,555)

(174,972)

253,478

Other assets

(363,626)

590,738

(504,429)

499,554

Trade accounts payable

44,736

126,499

188,822

267,063

Salaries and social charges

64,981

175,598

230,442

303,390

Tax obligations

(20,362)

(140,742)

288,869

(164,532)

Transactions with related parties

(281,170)

(2,201,814)

3,765

193,038

Provision for contingencies

(30,945)

(49,582)

(356,956)

(704,174)

Insurance and reinsurance assets (liabilities)

-

-

10,250,459

5,876,254

Other liabilities

72,181

176,996

(122,569)

(314,204)

3,436,173

1,765,061

7,695,597

4,813,337

Payment of interest

(4,478,843)

(3,095,288)

(4,423,242)

(3,124,891)

Payment of income and social contribution taxes

-

-

(994,041)

(896,199)

Net cash from (used in) operating activities (1,042,670)

(1,330,227)

2,278,314

792,247

Cash flows from investing activities

Payment in business acquisition, net of cash acquired

-

-

-

132

Cash from merger of subsidiary

-

(6)

-

-

Proceeds from disposal of equity interest, net of cash

714,143

1,225,931

714,143

-

Acquisition of equity interest

-

-

(129,200)

(1,666)

Advance for future capital increase

(433,578)

(683,746)

-

-

Additions to property and equipment

(879,017)

(571,631)

(2,195,432)

(2,268,589)

Additions to intangible assets

(51,611)

(67,545)

(129,603)

(212,186)

Acquisition of securities

(23,039,934)

(21,776,889)

(69,051,086)

(86,384,286)

Redemption of securities

23,529,412

21,581,910

68,216,973

84,526,533

Dividends and interest on equity received

1,257,397

1,973,370

14,017

45,071

Net cash from (used in) investing activities

1,096,812

1,681,394

(2,560,188)

(4,294,991)

Cash flows from financing activities

Treasury shares

(1,182,195)

(390,449)

(1,182,195)

(390,449)

Payment of dividends and IOE

(1,594,624)

(822,278)

(1,613,420)

(1,025,557)

Loans, financing and debentures raised

5,485,000

5,985,539

5,485,000

8,115,539

Payment of loans, financing and debentures

(1,721,002)

(3,504,901)

(1,863,754)

(3,624,777)

Settlement of swap

(527,088)

(380,715)

(1,021,130)

(551,698)

Accounts payable for acquisitions

-

-

(18,045)

(56,124)

Cash flow from (used in) financing activities

460,091

887,196

(213,544)

2,466,934

Increase (decrease) in cash and cash equivalents

514,233

1,238,363

(495,418)

(1,035,810)

Cash and cash equivalents at beginning of period

214,163

408,911

3,705,415

6,570,751

Cash and cash equivalents at end of period

728,396

1,647,274

3,209,997

5,534,941

See accompanying notes.

Statements of value added

Nine-month periods ended September 30, 2026 and 2025 (In thousands of Brazilian reais, unless otherwise stated)

Individual

Consolidated

09/30/2026

09/30/2025

09/30/2026

09/30/2025

Revenue

14,076,184

12,437,959

46,565,707

43,160,287

Sales of goods, products and services

14,301,444

13,011,903

21,634,450

19,903,143

Revenues from insurance operations

-

-

25,676,876

24,260,480

Allowance for expected credit losses

(638,078)

(576,884)

(1,260,746)

(1,094,642)

Other revenues

412,818

2,940

515,127

91,306

Benefits and claims

-

-

(14,178,675)

(14,840,788)

Expenses with benefits and redemptions

-

-

(14,178,675)

(14,840,788)

Materials acquired from third parties

(4,952,501)

(4,224,199)

(12,129,465)

(10,332,556)

Costs of sales

(4,506,011)

(4,109,012)

(10,652,317)

(9,581,357)

Materials, power, third-party services and other

(425,576)

(226,529)

(876,880)

(501,272)

Loss on/recovery of assets

(20,914)

111,342

(600,268)

(249,927)

Gross value added

9,123,683

8,213,760

20,257,567

17,986,943

Depreciation and amortization

(666,809)

(717,334)

(1,352,870)

(1,404,681)

Net value added

8,456,874

7,496,426

18,904,697

16,582,262

Value added received in transfer

7,341,918

5,661,966

6,981,314

5,740,381

Equity accounting

3,417,094

3,238,463

27,799

28,799

Finance income

3,924,824

2,423,503

9,594,228

8,191,258

Finance income (costs) from insurance contracts

-

-

(2,640,713)

(2,479,676)

Total value added

15,798,792

13,158,392

25,886,011

22,322,643

Distribution of value added

(15,798,792)

(13,158,392)

(25,886,011)

(22,322,643)

Personnel and related charges

(4,096,432)

(3,734,477)

(7,820,570)

(7,096,300)

Salaries

(3,671,717)

(3,326,922)

(6,913,750)

(6,228,867)

Benefits

(280,801)

(268,166)

(596,113)

(580,198)

Unemployment Compensation Fund (FGTS)

(143,914)

(139,389)

(310,707)

(287,235)

Taxes, charges and contributions

(535,839)

(267,284)

(3,067,507)

(2,574,487)

Federal taxes

(210,714)

15,563

(2,318,638)

(1,915,636)

State taxes

-

(191)

(32,663)

(38,175)

Local taxes

(325,125)

(282,656)

(716,206)

(620,676)

Debt remuneration

(7,713,769)

(5,640,657)

(11,333,247)

(8,999,190)

Interest

(7,497,602)

(5,434,678)

(10,850,249)

(8,488,006)

Rents

(8,217)

(8,059)

(23,970)

(78,022)

Other

(207,950)

(197,920)

(459,028)

(433,162)

Equity remuneration

(3,452,752)

(3,515,974)

(3,664,687)

(3,652,666)

Interest on equity

(1,150,000)

(1,350,000)

(1,150,000)

(1,350,000)

Dividends

-

-

(19,706)

(203,032)

Retained profits

(2,302,752)

(2,165,974)

(2,302,752)

(2,165,974)

Noncontrolling interests on retained profits

-

-

(192,229)

66,340

See accompanying notes.

Notes to the interim financial information September 30, 2026

(In thousands of Brazilian reais, unless otherwise stated)

  1. Operations

    Rede D'Or São Luiz S.A. (the "Company" or "Parent Company" and jointly with its subsidiaries "Rede D'Or" or "Group"), headquartered at Rua Francisco Marengo, 1.312, in the city and state of São Paulo, is engaged in the rendering of hospital services, offering assistance and hospitality concepts, creating medical and diagnostic excellence centers and generating medical knowledge and experience that ensure security to customers, either doctors, patients or healthcare plans.

    Through its subsidiaries and associates, the Company operates in the health (health and dental insurance, administrative services only (ASO) health and dental plans, and health and wellness solutions), life insurance, private pension, and asset management segments.

    Rede D'Or operates in the states of Rio de Janeiro, São Paulo, Pernambuco, Maranhão, Bahia, Sergipe, Paraná, Ceará, Minas Gerais, Mato Grosso do Sul, Paraíba, Alagoas, Pará and the Federal District, with 73 own hospitals in operation and over 20 projects under development, in addition to oncology and radiotherapy clinics and laboratories. Currently, the Group has 10,585 hospital beds in total.

    The first hospital unit, Hospital Barra D'Or, was opened in 1998, and Hospital Copa D'Or and Hospital Quinta D'Or were opened in 2000 and 2001, respectively. Since 2004, strategic partnerships have been made with other hospitals, thus increasing its range of expertise and reaching other areas in Rio de Janeiro. Also through partnerships and acquisitions, Rede D'Or started operations in the state of Pernambuco in 2007; in the states of Maranhão and Bahia in 2018; in the state of Sergipe in 2019; in the states of Paraná and Ceará in 2020; in the states of Minas Gerais, Mato Grosso do Sul and Paraíba in 2021; and in the state of Alagoas in 2022.

    In December 2022, the business combination between the Company and Sul América S.A. was completed through the merger of Sul América S.A. into Rede D'Or. As a result of the merger, Sul América S.A. was dissolved and succeeded by Rede D'Or as regards all its assets, rights and obligations, and Rede D'Or became the parent company of Sul América Group ("SASA" or "Sul América" - comprising the subsidiaries, associates and investment funds remaining from the merger of Sul América S.A.).

    Seasonality

    There are no significant seasonal effects on the Company's operations; however, a smaller volume of customers and, consequently, of claims in the insurance and health insurance businesses, is generally observed in December, January and February due to year-end

    celebrations and vacation period, and a larger volume of customers is observed in winter.

    Notes to the interim financial information September 30, 2026

    (In thousands of Brazilian reais, unless otherwise stated)

  2. Accounting policies

    This individual and consolidated interim financial information was prepared in accordance with Accounting Pronouncement CPC 21 (R1) - Interim Financial Reporting, issued by the Brazilian Accounting Pronouncements Committee ("CPC"), and in accordance with IAS 34 - Interim Financial Reporting, issued by the International Accounting Standards Board (IASB), and is presented in accordance with the rules issued by the Brazilian Securities and Exchange Commission ("CVM") applicable to the preparation of Quarterly Information Form (ITR). The statements of value added are presented as supplementary information for IFRS purposes.

    The accounting policies as well as estimates and critical accounting judgments adopted by the Group in this interim financial information are consistent with those adopted in the financial statements for the year ended December 31, 2025, disclosed on February 25, 2026.

    Profit or loss for the nine-month period ended September 30, 2026 are not necessarily indicative of the profit or loss that may be expected for the full year ending December 31, 2026. The interim financial information and related notes do not include all information and disclosures required for the annual financial statements. As such, this interim financial information must be read together with the audited annual financial statements as of December 31, 2025.

    Authorization to complete the preparation of this interim financial information was provided by the Company management on November 11, 2026.

    The individual and consolidated interim financial information includes the operations of the Company and its subsidiaries, as presented in Note 8. Additionally, as of September 30, 2026, the Company holds investments in funds-of-one that are fully consolidated.

  3. Atlântica Hospitais transactions

    On August 16, 2024, the Company entered into a partnership with Atlântica Hospitais e Participações S.A. ("Atlântica Hospitais") - a company focused on investments in hospitals and an indirect subsidiary of Bradseg Participações S.A., which in turn is the parent of Bradesco Seguros Group - for the creation of the new hospital network "Atlântica D'Or" (Pacífico Holding Imobiliária Hospitalar S.A. and Pacífico Operações Hospitalares S.A.). The Partnership consists of a corporate association for investments in, construction, development and operation of hospitals, with Rede D'Or holding a 50.01% interest and acting as the hospital operator and controlling shareholder of the new Atlântica D'Or hospital network, and Atlântica Hospitais holding a 49.99% interest. The Partnership encompasses all investments and assets, including real estate assets, related to the hospitals

    Notes to the interim financial information September 30, 2026

    (In thousands of Brazilian reais, unless otherwise stated)

    On September 1, 2025, the Company entered into an investment, purchase and sale and other covenants agreement with Atlântica Hospitais for the contribution of assets and liabilities of Hospital Glória D'Or and SPE IH Glória D'Or, located in the city of Rio de Janeiro, to the Atlântica D'Or hospital network, with Rede D'Or holding a 50.01% interest and Atlântica Hospitais holding a 49.99% interest. On January 30, 2026, the Company completed the contribution of the assets and liabilities of Hospital Glória D'Or and SPE IH Glória D'Or to Atlântica D'Or. The Company received R$452,037 in connection with the acquisition of the shares corresponding to a 49.99% equity interest.

    On November 10, 2025, the Company entered into an investment, purchase and sale and other covenants agreement with Atlântica Hospitais for the contribution of the hospital operations of Maternidade São Luiz Star ("Maternidade Star"), located in the city of São Paulo, to the Atlântica D'Or hospital network, with Rede D'Or holding a 50.01% interest and Atlântica Hospitais holding a 49.99% interest. The transaction does not include the real property in which Maternidade Star's activities are conducted, which will continue to be wholly owned by the Rede D'Or group. On February 26, 2026, the Company completed the closing of the contribution of the assets and liabilities of Maternidade Star to Atlântica D'Or. The Company received R$224,326 in connection with the acquisition of the shares corresponding to a 49.99% equity interest.

    On May 26, 2026, the Company entered into an investment, purchase and sale and other covenants agreement with Atlântica Hospitais and Atlântica Empreendimentos Imobiliários Ltda. ("Atlântica") for the contribution to the Atlântica D'Or hospital network of properties located in the district of São Conrado, in the city of Rio de Janeiro, State of Rio de Janeiro, where Hospital São Conrado D'Or will be developed and operated, with Rede D'Or holding a 50.01% interest and Atlântica holding a 49.99% interest. On July 13, 2026, the Company completed the closing of the contribution of certain properties owned by Rede D'Or to Atlântica D'Or. The consideration of R$60,582, corresponding to the acquisition of a 49.99% interest, will be paid in full by January 2027.

    On September 2, 2026, the Company entered into an investment, purchase and sale and other covenants agreement with Atlântica Hospitais for the contribution of Hospital Biocor, located in the city of Nova Lima, in the Belo Horizonte metropolitan area, State of Minas Gerais ("Hospital Biocor"), to the "Atlântica D'Or" hospital network, a corporate partnership in which Rede D'Or, its hospital operator, holds a 50.01% interest and Atlântica holds a 49.99% interest. The Company will receive approximately R$130,000, to be adjusted based on changes in the Interbank Deposit Certificate (CDI) rate through the closing of the transaction. Completion of the transaction is subject to the fulfillment of certain conditions precedent customary for transactions of this nature, including the applicable regulatory approvals.

    On September 16, 2026, Atlântica D'Or completed the acquisition of certain real estate assets intended for the construction and future operation of a hospital in the city of Jundiaí, State of São Paulo. Rede D'Or will be responsible for managing the unit, and the existing ownership structure of the partnership will be maintained, with Rede D'Or holding a 50.01% interest and Atlântica holding a 49.99% interest.

    Notes to the interim financial information September 30, 2026

    (In thousands of Brazilian reais, unless otherwise stated)

    As of September 30, 2026, the partnership encompasses six hospitals in operation (São Luiz Guarulhos, São Luiz Alphaville, Macaé D'Or, Hospital São Luiz Campinas, Hospital Glória D'Or and Maternidade São Luiz Star) and five other projects under development (located in Ribeirão Preto, Taubaté, Sorocaba, São Conrado and Jundiaí).

  4. Cash and cash equivalents and s ecurities
    1. Cash and cash equivalents

      Individual Consolidated

      09/30/2026

      12/31/2025

      09/30/2026

      12/31/2025

      Cash and cash equivalents Cash and banks

      9,511

      13,626

      46,459

      63,526

      Marketable securities

      718,885

      200,537

      3,163,538

      3,641,889

      Cash and cash equivalents

      728,396

      214,163

      3,209,997

      3,705,415

      Marketable securities classified as cash equivalents have maturities of less than three months from the date of acquisition and have an insignificant risk of changes in value.

    2. Securities

      Securities are broken down in the table below, which shows their respective classifications, curve value and market value, as well as the contractual average rates:

      Fair value through profit

      Individual

      or loss Amortized cost

      09/30/2026

      12/31/2025

      Description

      Market value/ carrying

      amount

      Curve value/carrying

      amount Market value

      Average interest rate (a)

      Total

      Average interest rate (a)

      Total

      Fixed income securities - corporate bonds

      6,584,928

      6,984,043

      7,105,528

      Bank deposit certificates

      Floating rate CDI %

      Debentures

      Floating rate CDI +

      6,462,250

      -

      399,115

      -

      -

      399,115

      100.83% CDI

      CDI+4.00% p.a.

      6,462,250

      399,115

      101.68% CDI

      -

      6,965,003

      -

      Financial bills

      Floating rate CDI +

      122,678

      -

      -

      CDI+0.14% p.a.

      122,678

      CDI+0.27% p.a.

      84,556

      Floating rate CDI %

      Fixed income securities -

      -

      -

      -

      -

      -

      105.00% CDI

      55,969

      government securities

      1,964,323

      1,964,323

      1,304,929

      Financial treasury bills National treasury bills

      1,512,709

      -

      -

      SELIC

      1,512,709

      SELIC

      1,304,929

      Fixed rate

      451,614

      -

      -

      14.03% p.a.

      451,614

      -

      -

      Investment fund shares

      Investment fund shares - other than funds-of-one

      217,241

      217,241

      -

      -

      -

      217,241

      217,241

      -

      26

      26

      9,165,607

      8,410,483

      Current

      8,766,492

      Current

      8,410,483

      Noncurrent

      399,115

      Noncurrent

      -

      Fair value through profit or loss

      Market value/

      Fair value through other

      comprehensive income Amortized cost

      Market

      value/ Curve

      Consolidated

      09/30/2026 Average rate 12/31/2025

      Description Carrying amount Curve value

      Carrying

      amount

      value/carrying

      amount

      Market

      value

      Average

      interest rate(a)

      Total

      interest (a)

      Total

      Fixed income securities - corporate

      bonds 11,465,367 897,378

      880,223

      399,115

      399,115

      12,744,705

      14,199,719

      Bank deposit certificates

      Floating rate CDI +

      6,199

      -

      -

      -

      -

      CDI+0.26% p.a.

      6,199

      CDI+0.26% p.a.

      19,721

      Floating rate CDI % Debentures

      7,582,979

      -

      -

      -

      -

      100.82% CDI

      7,582,979

      101.69% CDI

      9,715,947

      Fixed rate

      78,242

      -

      -

      -

      -

      13.7% p.a.

      78,242

      12.79% p.a.

      73,366

      Floating rate CDI +

      1,011,748

      98,430

      99,517

      399,115

      399,115

      CDI+2.12% p.a.

      1,510,380

      CDI+1.72% p.a.

      1,204,552

      Floating rate CDI %

      16,660

      -

      -

      -

      -

      106.2% CDI

      16,660

      116.96% CDI

      3,237

      Floating rate IPCA

      818,909

      -

      -

      -

      -

      IPCA+8.08% p.a.

      818,909

      IPCA+7.29% p.a.

      580,135

      Floating rate IGP-M Financial bills

      -

      110,258

      98,004

      -

      -

      IGPM+5.84% p.a.

      98,004

      IGPM+5.84% p.a.

      95,522

      Fixed rate

      9,611

      -

      -

      -

      -

      14.43% fixed rate

      9,611

      -

      -

      Floating rate CDI +

      1,768,808

      -

      -

      -

      -

      CDI+0.29% p.a.

      1,768,808

      CDI+0.47% p.a.

      1,683,459

      Floating rate CDI %

      68,137

      -

      -

      -

      -

      101.73% CDI

      68,137

      108.99%CDI

      116,001

      Floating rate IPCA

      -

      658,253

      651,895

      -

      -

      IPCA+8.17% p.a.

      651,895

      IPCA+8.17% p.a.

      610,887

      Promissory notes

      Mortgage-backed Securities ("CRI")

      6,346

      30,437

      30,807

      -

      -

      CDI+1.57% p.a.

      37,153

      CDI+1.54% p.a.

      40,872

      CRI Fixed rate

      10,486

      -

      -

      -

      -

      15.33% p.a.

      10,486

      15.86% p.a.

      1,213

      Floating rate CDI +

      14,162

      -

      -

      -

      -

      CDI+1.64% p.a.

      14,162

      -

      -

      Time deposits with special guarantee (DPGE)

      73,080

      -

      -

      -

      -

      CDI+0.4% p.a.

      73,080

      CDI+0.49% p.a.

      54,807

      Fixed income securities -government securities

      18,914,091

      3,827,461

      3,793,114

      3,959,065

      3,838,880

      26,666,270

      20,249,429

      Financial treasury bills National treasury bills

      16,290,397

      17,135

      17,167

      -

      -

      SELIC

      16,307,564

      SELIC

      13,381,692

      Fixed rate

      National treasury notes

      2,269,774

      -

      -

      -

      -

      13.98% p.a.

      2,269,774

      13.43% p.a.

      600,028

      Series F - Fixed rate

      336

      19,560

      18,478

      -

      -

      9.27% p.a.

      18,814

      9.27% p.a.

      19,012

      Series B - Floating rate IPCA

      39,067

      3,463,354

      3,436,735

      74,493

      66,459

      IPCA+7.2% p.a.

      3,550,295

      IPCA+6.42% p.a.

      1,903,885

      Series C - Floating rate IGP-M

      78,057

      327,412

      320,734

      1,735,056

      1,622,905

      IGPM+5.94% p.a.

      2,133,847

      IGPM+5.94% p.a.

      2,164,767

      Fixed income securities abroad

      236,460

      -

      -

      2,149,516

      2,149,516

      13.86% p.a.

      2,385,976

      13.86% p.a.

      2,180,045

      Variable income securities

      212,268

      212,268

      227,711

      Shares

      212,268

      -

      -

      -

      -

      -

      212,268

      -

      227,711

      Investment fund shares

      4,442,465

      4,442,465

      3,949,500

      Fixed income, private equity and multimarket investment fund

      shares

      4,417,966

      -

      -

      -

      -

      -

      4,417,966

      -

      3,922,215

      Equity investment fund shares

      24,499

      -

      -

      -

      -

      -

      24,499

      -

      27,285

      Other investments

      10,642

      -

      -

      -

      -

      - 10,642

      - 3,820

      44,076,350

      38,630,179

      Current 39,447,148

      Current 36,855,083

      Noncurrent 4,629,202

      Noncurrent 1,775,096

      (a) For securities classified as at fair value through profit or loss (FVPL), average market rates are used. For those classified as at fair value through other comprehensive income (FVOCI) and at amortized cost, acquisition rates (yield curve) are used for interest accrual purposes, while assets classified as FVOCI are also marked to market for fair value measurement purposes.

  5. Accounts receivable

    Individual Consolidated

    Description Note 09/30/2026 12/31/2025 09/30/2026 12/31/2025

    Accounts receivable - hospital services

    5.1

    5,402,603

    5,312,008

    9,078,737

    8,689,373

    Other accounts receivable

    5.2

    -

    -

    3,215,082

    3,212,746

    5,402,603 5,312,008 12,293,819 11,902,119

    Current

    5,402,603

    5,312,008

    10,511,349

    10,167,395

    Noncurrent

    -

    -

    1,782,470

    1,734,724

    1. Hospital services

      Trade accounts receivable comprise receivables from healthcare companies and individuals, as follows:

      Individual Consolidated

      09/30/2026

      12/31/2025

      09/30/2026

      12/31/2025

      Accounts receivable from health insurance and health plans

      6,452,597

      6,282,646

      10,654,321

      10,236,070

      Accounts receivable from individuals Allowance for expected credit losses and

      86,737

      116,415

      176,740

      213,927

      provision for disallowances (1,136,731)

      (1,087,053)

      (1,752,324)

      (1,760,624)

      5,402,603

      5,312,008

      9,078,737

      8,689,373

      Changes in provision for disallowances and allowance for expected credit losses

      Individual Consolidated 09/30/2026 09/30/2025 09/30/2026 09/30/2025

      Balance at beginning of period

      (1,087,053)

      (1,114,970)

      (1,760,624)

      (1,873,401)

      (Recognition)/reversal of

      provision for disallowances and

      allowance for expected credit losses

      (638,078)

      (576,884)

      (1,231,313)

      (1,072,512)

      Write-offs (a)

      573,946

      550,640

      1,239,613

      1,105,628

      Provision arising from the transfer of

      assets (b)

      14,454

      16,533

      -

      -

      Transfer to assets available for sale

      -

      -

      -

      53,342

      Balance at end of period

      (1,136,731)

      (1,124,681)

      (1,752,324)

      (1,786,943)

      1. Write-offs include the derecognition of uncollectible amounts and elimination of accepted disallowances among Group companies.

      2. Transfer of assets from Hospital Maternidade São Luiz Star in 2026 and Hospital São Luiz Campinas in 2025.

        At September 30, 2026 and December 31, 2025, the aging list of trade accounts receivable was as follows:

        1 - 31 -

        Individual

        61 -

        Past due 91 -

        121 -

        181 -

        360 -

        Total Falling due 30 days 60 days 90 days 120 days 180 days 360 days 720 days

        09/30/2026 6,539,334

        4,466,008

        154,429

        123,979

        131,966 202,758

        251,852

        544,866

        663,476

        12/31/2025 6,399,061

        4,263,759

        149,692

        162,354

        149,863 197,343

        246,512

        533,617

        695,921

        1 - 31 -

        Consolidated

        61 -

        Past due 91 -

        121 -

        181 -

        360 -

        Total Falling due 30 days 60 days 90 days 120 days 180 days 360 days 720 days

        09/30/2026 10,831,061

        6,910,406

        448,892

        203,026

        246,616

        232,753

        407,508

        1,012,196 1,369,664

        12/31/2025 10,449,997

        6,265,931

        598,516

        298,737

        267,530

        234,563

        423,324

        900,188 1,461,208

        The Company's revenues arise from the provision of hospital services, including the use of medicines and hospital materials. Revenue is recognized to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably

        measured, i.e. upon rendering of medical services at an amount that reflects the consideration to which an entity expects to be entitled in exchange for providing services to a customer.

        Changes in provision for disallowances and allowance for expected credit losses

        The provision for disallowances and allowance for expected credit losses are presented reducing the balance of accounts receivable and recognized at an amount deemed sufficient by management to cover any expected losses on the realization of amounts billed.

        The Company's criterion to recognize a provision for disallowances is to annually analyze the performance of notes overdue between 360 to 720 days, a period deemed sufficient for exhausting the collection process. The percentage reached is applied to the gross revenue recorded and recognized as a provision in current profit or loss, reflecting management's best expectation based on the analyzed history. The analysis is made individually by cash-generating unit, as well as the percentage recorded as a provision for disallowances in the year.

        As a criterion for the recognition of an allowance for expected credit losses, an individual analysis of receivables is performed to identify specific counterparty risks. If necessary, an allowance for expected credit losses is recorded for the partial or total balance of

        receivables outstanding of these customers.

        5.2.

        Other accounts receivable

        Consolidated

        Description

        Note

        09/30/2026

        12/31/2025

        Other operating receivables

        5.2.1

        2,105,337

        1,996,059

        Consideration receivable - ASO health plans

        5.2.2

        938,341

        1,067,960

        Other (a)

        171,404

        148,727

        3,215,082

        3,212,746

        Current

        1,432,612

        1,478,022

        Noncurrent

        1,782,470

        1,734,724

        (a) This balance is represented mainly by receivables related to securities obligations and receivables not directly related to insurance operations, in subsidiaries that operate in this industry.

        1. Other operating receivables

          Consolidated

          09/30/2026

          12/31/2025

          Receivables from FCVS - SFH

          Principal (Note 5.2.1.1)

          1,972,509

          1,957,587

          Impairment (Note 5.2.1.1)

          (221,281)

          (221,281)

          Frozen funds (a)

          144,741

          102,802

          Other (b)

          209,368

          156,951

          Total

          2,105,337

          1,996,059

          Current

          323,870

          264,847

          Noncurrent

          1,781,467

          1,731,212

          5.2.1.1. Receivables from FCVS - SFH

          Consolidated

          Description

          09/30/2026

          Balance of receivables FCVS-SFH at 12/31/2025

          1,957,587

          Additions

          154,783

          Write-offs

          (139,861)

          Balance of receivables FCVS-SFH at 09/30/2026

          1,972,509

          Balance of impairment at 09/30/2026

          (221,281)

          Closing balance net of impairment at 09/30/2026

          1,751,228

          Current

          95,070

          Noncurrent

          1,656,158

          1. These refer to funds frozen in bank accounts and investment funds related to lawsuits.

          2. This balance is mainly represented by advances to suppliers.

          Consolidated

          Description

          12/31/2025

          Balance of receivables FCVS-SFH at 12/31/2024

          2,028,967

          Additions

          216,048

          Write-offs

          (287,428)

          Balance of receivables FCVS-SFH at 12/31/2025

          1,957,587

          Balance of impairment at 12/31/2025

          (221,281)

          Closing balance net of impairment at 12/31/2025

          1,736,306

          Current

          99,829

          Noncurrent

          1,636,477

          As at September 30, 2026, there are lawsuits in progress related to the Housing Financial System (SH/SFH) in which the Company has been summoned. Such lawsuits may give rise to future cash disbursement with the corresponding request for reimbursement to Caixa Econômica Federal (CAIXA), manager of the Wage Variation Compensation Fund (FCVS). In the cases in which the lawsuit is in the provisional enforcement phase to avoid early disbursement in cases for which decisions are not final and unappealable, the Company pledges in court surety bond policies. As of September 30, 2026, the total amount secured by surety bonds was R$1,126,315 (R$1,123,206 as of December 31, 2025). The SH/HFS was established by article 14 of Law No. 4380/1964 and, since 1967, has been guaranteed by the FCVS. Insurance companies have lawsuits filed against them because they are mischaracterized as representatives of the FCVS, which is the role of CAIXA, the manager of that Fund. In view of this role of FCVS representative in lawsuits, the insurance companies, which are the illegitimate parties, are entitled to receive reimbursements for all incurred expenditures. Law No. 12409/2011, amended by Law No. 13000/2014, as well as the CCFCVS Resolution No. 364 of March 28, 2014, expressly establish the responsibility of FCVS, through its manager CAIXA, for all lawsuits relating to the SH/SFH's public policy. Currently, insurance companies are reimbursed by the FCVS for payments made in connection with SH/SFH-related lawsuits, based on the criteria established by CCFCVCS Resolution No. 448/2019 and restated by reference to the variation of the Referential Rate ("TR") between the date of payment of each expense and the date of effective reimbursement.

        2. Consideration receivable - ASO health plans

        Administrative service only (ASO) health plans are plans in which the Company administers medical and hospital expenses on behalf of its customers, and is fully reimbursed by the customers, recording only its administration fee as revenue. The amounts related to consideration receivable by maturity are as follows:

        Consolidated

        09/30/2026

        12/31/2025

        Falling due

        Falling due from 1 to 30 days

        851,393

        950,854

        Falling due from 31 to 60 days

        40,255

        36,247

        Falling due from 61 to 180 days

        655

        16,111

        Total falling due

        892,303

        1,003,212

        Past due

        Past due from 1 to 30 days

        43,239

        50,711

        Past due from 31 to 60 days

        1,224

        14,617

        Past due from 61 to 180 days

        3,574

        1,018

        Past due from 181 to 365 days

        352

        854

        Past due for more than 365 days

        3,700

        3,100

        Total

        52,089

        70,300

        Provision for impairment

        (6,051)

        (5,552)

        Total past due

        46,038

        64,748

        Total unearned premiums

        944,392

        1,073,512

        Total provision for impairment

        (6,051)

        (5,552)

        Total

        938,341

        1,067,960

  6. Inventories

    Individual Consolidated

    09/30/2026

    12/31/2025

    09/30/2026

    12/31/2025

    Medicines

    231,595

    190,064

    464,028

    412,321

    Special materials

    153,830

    141,241

    328,619

    293,537

    Disposable materials

    121,016

    119,507

    280,475

    298,194

    Consumables

    39,205

    42,654

    101,428

    93,786

    Laboratory materials

    9,390

    10,022

    32,613

    39,570

    Surgical sutures

    8,390

    9,176

    16,310

    18,065

    Dressing room materials

    4,976

    5,035

    15,729

    14,923

    Food stuff

    6,354

    6,817

    11,316

    12,431

    Other

    8,026

    3,262

    25,517

    13,283

    582,782

    527,778

    1,276,035

    1,196,110

  7. Transactions with related parties

    Significant related-party transactions

    The nature of significant related-party transactions is summarized below:

    1. Leases - the Company leases properties owned by the controlling shareholders, namely: properties of the hospitals Copa D'Or and Quinta D'Or, and the property of the administrative unit. Leases are at market value and generated an expense in profit or loss for the period ended September 30, 2026 of R$28,748 (R$21,845 at September 30, 2025), referring to interest and amortization of rights of use. Leases are annually restated by reference to the Extended Consumer Price Index (IPCA).

    2. Trans fers of funds between companies - to enhance the operations of certain investees and provide funds for expansion and/or acquisitions, management transfers funds between Group companies under current account remittance agreements entered into between the parties. These balances are substantially eliminated in the consolidated financial statements.

    3. Shared services - these are centralized services rendered by the parent company, Rede D'Or, such as legal assistance, marketing, accounting, treasury, accounts payable and accounts receivable, which are shared among the other entities of the Group based on apportionment criteria that take into consideration the contribution of each entity to the consolidated gross revenue.

    4. Debentures - certain subsidiaries issued nonconvertible debentures, which were acquired by the parent company. These debentures are intended to provide funds to the investees for investment in operations and expansion.

    5. Book-entry commercial papers- certain subsidiaries carried out a private placement of book-entry nonconvertible commercial papers, in specific cases, convertible into equity interests, with all of these commercial papers being acquired by the parent company. These commercial papers are intended to provide funds to the investees for investment in operations and expansion.

    6. Revenues and accounts receivable partially arise from commercial transactions conducted in the ordinary course of business relating to medical care provided to members of Sul América plans. These transactions have reference tables by type of service provided by the Company with Sul América and the maturities of these services are stipulated in a contract entered into between the parties.

      In addition to the balances presented in the tables below, the Parent Company and subsidiary Rede D'Or Finance carried out four debenture issue and purchase transactions: (i) on January 17, 2018, subsidiary Rede D'Or Finance issued senior notes totaling US$500,000 thousand, and at the same time, the Parent Company issued debentures (10th issue), which were partially acquired by other investors and by subsidiary Rede D'Or Finance (Note 13); (ii) on January 22, 2020, subsidiary Rede D'Or Finance carried out the second issue of senior notes, in the total amount of US$850,000 thousand. On February 13, 2020, Rede D'Or Finance reopened the second issue of senior notes and issued an additional US$350,000 thousand in notes with the same characteristics as the initial issue. In addition, on April 17, 2020, the Parent Company issued debentures (17th issue - 1st series), which were acquired by subsidiary Rede D'Or Finance; (iii) on September 9, 2025, subsidiary Rede D'Or Finance carried out its third issue of senior notes, for a total amount of US$500,000 thousand. In addition, on September 30, 2025, the Parent Company issued debentures (37th issue), which were acquired by subsidiary Rede D'Or Finance. The respective debentures were offered through placement efforts abroad, in accordance with the applicable legislation; and (iv) on April 28, 2026, subsidiary Rede D'Or Finance completed its fourth issue of senior notes, in the total amount of US$500,000 thousand. In addition, on May 26, 2026, the Parent Company issued debentures (40th issue), which were acquired by subsidiary Rede D'Or Finance. The respective debentures were issued through private placement efforts abroad, in accordance with the applicable law.

      Balances with related parties

      Individual

      09/30/2026

      12/31/2025

      09/30/2025

      Current

      Noncurrent Noncurrent

      Current

      Noncurrent

      Company

      assets

      assets liabilities

      Profit or loss

      assets

      assets

      Profit or loss

      P&L

      Debentures Norte D'Or (g)

      23,743

      -

      -

      3,984

      27,506

      -

      5,633

      3,515

      Debentures São Lucas (h)

      499,594

      -

      -

      60,776

      427,570

      -

      50,492

      31,922

      Debentures Hospital Nossa Senhora das Neves (c)

      165,703

      -

      -

      27,052

      354,236

      -

      57,869

      42,227

      Debentures Biocor (d)

      -

      -

      -

      8,446

      108,177

      -

      14,727

      10,016

      Debentures São Carlos (f)

      156,244

      -

      -

      18,126

      131,552

      -

      17,847

      12,029

      Debentures Proncor (i)

      333,105

      -

      -

      39,353

      259,139

      -

      26,059

      15,607

      Debentures Acreditar (j)

      54,323

      -

      -

      6,577

      47,746

      -

      21,720

      15,076

      Debentures Onco Dor (k)

      -

      303,043

      -

      36,690

      266,353

      -

      31,353

      19,573

      Debentures Oncologistas (m)

      8,929

      365,792

      -

      49,285

      26,790

      365,792

      27,028

      9,535

      Debentures São Rafael (n)

      5,728

      270,000

      -

      31,629

      17,092

      270,000

      17,092

      6,763

      Debentures Cia Saúde (o)

      55,271

      1,000,000

      -

      111,907

      15,579

      1,000,000

      15,579

      -

      Debentures Mederi (p)

      196,312

      -

      -

      17,813

      -

      -

      -

      -

      Book-entry commercial papers Onco Star SP (e)

      -

      1,755,154

      -

      177,785

      -

      1,553,594

      198,120

      141,725

      Book-entry commercial papers Cehon (l)

      97,748

      -

      -

      11,834

      85,913

      -

      10,113

      6,313

      Shared services

      Medise Medicina Diagnóstico e Serviços Ltda.

      -

      -

      -

      11,121

      -

      -

      14,987

      11,564

      Hospital Esperança S.A.

      -

      -

      -

      39,884

      -

      -

      51,006

      37,751

      Hospital São Marcos S.A.

      -

      -

      -

      4,775

      -

      -

      8,046

      6,419

      Hospital Norte D'Or de Cascadura S.A.

      -

      1,453

      -

      8,766

      -

      -

      11,768

      10,062

      J. Badim S.A.

      -

      26,987

      -

      2,320

      -

      25,786

      2,917

      2,711

      Oncologia D'Or S.A.

      -

      10,829

      -

      90,473

      -

      16,912

      106,585

      72,609

      Hospital Fluminense S.A.

      -

      -

      -

      19,371

      -

      -

      24,405

      16,064

      H. Integrados da Gávea ("Clínica São Vicente")

      -

      -

      -

      14,817

      -

      -

      20,732

      14,769

      Hospital Alpha-Med LTDA.

      -

      -

      -

      4,783

      -

      -

      5,275

      3,865

      Hospital UDI

      -

      -

      -

      12,812

      -

      -

      18,693

      15,155

      Onco Star SP

      -

      3,384

      -

      30,621

      -

      3,650

      35,502

      26,854

      DF Star

      -

      -

      -

      24,313

      -

      -

      31,572

      20,494

      Samer

      -

      -

      -

      7,087

      -

      -

      9,072

      6,887

      São Lucas

      -

      1,765

      -

      15,760

      -

      1,908

      20,030

      14,965

      São Rafael

      -

      4,675

      -

      38,099

      -

      8,836

      52,448

      35,776

      Hospital Santa Cruz

      -

      -

      -

      12,149

      -

      -

      17,374

      12,451

      Hospital Aliança

      -

      -

      -

      23,765

      -

      -

      30,264

      22,146

      São Carlos

      -

      914

      -

      9,270

      -

      2,882

      12,509

      7,977

      Cárdio Pulmonar

      -

      -

      -

      13,622

      -

      -

      20,066

      15,796

      Hospital Brasil Mauá

      -

      -

      -

      12,450

      -

      -

      16,847

      12,585

      Hospital Balbino

      -

      -

      -

      2,600

      -

      -

      3,968

      2,615

      Biocor H. de Doenças Cardiovasculares ("Biocor")

      -

      -

      -

      8,970

      -

      1,634

      13,103

      9,029

      Proncor Unidade Intensiva Cardiorespiratória

      -

      1,154

      -

      4,439

      -

      1,247

      5,747

      3,725

      Hospital Nossa Senhora das Neves

      -

      1,309

      -

      12,295

      -

      2,323

      16,113

      11,295

      Hospital Novo Atibaia

      -

      -

      -

      11,751

      -

      -

      16,121

      9,208

      Hospital Memorial Arthur Ramos

      -

      -

      -

      9,242

      -

      -

      13,091

      8,314

      Hospital Guarulhos

      -

      2,173

      -

      18,263

      -

      20,042

      18,697

      9,200

      Hospital Alphaville

      -

      2,250

      -

      18,499

      -

      19,940

      18,928

      7,056

      Hospital Macaé

      -

      841

      -

      7,717

      -

      9,014

      8,795

      5,995

      Hospital Campinas

      -

      2,390

      -

      21,035

      -

      5,594

      16,598

      9,595

      Maternidade Star

      -

      1,391

      -

      10,072

      -

      -

      -

      -

      Glória D'Or

      -

      2,247

      -

      13,121

      -

      -

      16,041

      12,917

      Other

      -

      2,713

      -

      52,655

      -

      5,083

      69,281

      49,017

      JMJB Diagnósticos e Serviços Hospitalares S.A. (a)

      -

      8,610

      -

      -

      -

      10,609

      -

      -

      J. Badim S.A. (a)

      -

      7,846

      -

      -

      -

      7,308

      -

      -

      Rede D'Or Finance

      -

      263,891

      -

      -

      -

      263,891

      -

      -

      Other

      -

      -

      8,984

      29,253

      7,636

      35,820

      32,800

      22,832

      1,596,700

      4,040,811

      8,984

      1,217,427

      1,775,289

      3,631,865

      1,253,013

      841,999

      Balances with related parties

      Consolidated

      09/30/2026 12/31/2025 09/30/2025

      Company

      Noncurrent assets

      Noncurrent liabilities

      Profit or loss

      Noncurrent assets

      Current liabilities

      Noncurrent liabilities

      Profit or loss

      P&L

      Debentures Biocor (d)

      -

      -

      (313)

      -

      16,860

      -

      (2,629)

      (1,883)

      Shared services

      J. Badim S.A.

      26,987

      -

      2,320

      25,786

      -

      -

      2,917

      2,711

      New Surgical Materiais Cirúrgicos (a)

      -

      -

      -

      21,523

      -

      -

      -

      -

      JMJB Diagnósticos e Serviços Hospitalares

      S.A.

      8,024

      -

      -

      10,609

      -

      -

      -

      -

      J Badim S.A. (a)

      8,762

      -

      -

      8,221

      -

      -

      -

      -

      JM&AM Empreendimentos Imobiliários S.A. (b)

      -

      -

      28,748

      370

      -

      -

      31,294

      21,845

      Other

      10,841

      5,422

      -

      7,645

      -

      4,337

      164

      150

      54,614

      5,422

      30,755

      74,154

      16,860

      4,337

      31,746

      22,823

      1. Transfers of funds for acquisition of companies, properties, expansion of operations, among others. These balances are substantially eliminated in the consolidated financial statements.

      2. Lease of properties owned by the controlling shareholders of Rede D'Or.

      3. On December 18, 2025, Hospital Nossa Senhora das Neves conducted the eighth private issue of nonconvertible, single-series, registered debentures in the amount of R$212,260, maturing on December 20, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit

        Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On January 2, 2026, Hospital Nossa Senhora das Neves conducted the ninth private issue of nonconvertible, single-series, registered debentures in the amount of R$146,251, maturing on December 30, 2026. The debentures may be fully or partially

        subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 2.90% p.a. On March 16, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

      4. On December 19, 2023, Biocor conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$33,691, initially maturing on December 19, 2024; however, this term was extended to December 20, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.0% p.a. On June 23, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

        On October 10, 2025, Biocor conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$13,000, maturing on October 10, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. On June 23, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

        On February 6, 2026, Biocor conducted the eighth private issue of nonconvertible, single-series, registered debentures

        in the amount of R$36,200, maturing on February 10, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. On June 23, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

        On May 11, 2026, Biocor conducted the ninth private issue of nonconvertible, single-series, registered debentures in the amount of R$35,000, maturing on May 10, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or.

        Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. On June 23, 2026, the debenture was early settled, with payment of interest and principal up to that date, plus yield. There are no guarantees for the debentures.

      5. On December 29, 2023, Onco Star SP Oncologia Ltda. carried out a private placement of book-entry convertible commercial papers, without security interest or collateral security system, in a single series, of first issue, in the amount of R$1,082,544, maturing on December 29, 2030. The commercial papers may be fully or partially subscribed until the maturity date by Rede D'Or. Commercial papers not subscribed after this period will be automatically canceled. The commercial papers earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.0% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees.

        On December 29, 2024, Onco Star SP Oncologia Ltda. carried out a private placement of book-entry convertible commercial papers, without security interest or collateral security system, in a single series, of second issue, in the amount of R$150,000, maturing on December 29, 2030. The commercial papers may be fully or partially subscribed until the maturity date by Rede D'Or. Commercial papers not subscribed after this period will be automatically canceled. The commercial papers earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.0% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees.

        On March 31, 2026, Onco Star SP Oncologia Ltda. carried out the third private placement of book-entry convertible commercial papers, without security interest or collateral security system, in a single series, of third issue, in the amount of R$180,000, maturing on December 29, 2030. The commercial papers may be fully or partially subscribed until the maturity date by Rede D'Or. Commercial papers not subscribed after this period will be automatically canceled. The commercial papers earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.0% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees.

      6. On May 20, 2025, São Carlos conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$32,862, maturing on May 20, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On January 15, 2026, São Carlos conducted the eighth private issue of nonconvertible, single-series, registered debentures in the amount of R$132,111, maturing on January 20, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On June 5, 2026, São Carlos conducted the ninth private issue of nonconvertible, single-series,

        registered unsecured debentures in the amount of R$159,000, maturing on June 10, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. As of September 30, 2026, R$5,000 had been subscribed. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the variation of the DI (Interbank Deposit) rate plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      7. On February 6, 2025, Norte D'Or conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$17,343, initially maturing on February 6, 2026; however, this term was extended to February 6, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. until April 10, 2025 and 10.03% p.a. from April 10, 2025. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On April 30, 2025, Norte D'Or conducted the eighth private issue of nonconvertible, single-series, registered debentures in the amount of R$5,430, initially maturing on October 30, 2025; however, this term was extended to April 30, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of

        the CDI (Interbank Deposit Certificate) plus 10.03% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      8. On March 13, 2025, São Lucas conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$15,000, maturing on March 27, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On May 13, 2025, São Lucas conducted the eighth private issue of nonconvertible, single-series, registered debentures in the amount of R$52,176, maturing on May 13, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On May 20, 2025, São Lucas conducted the ninth private issue of nonconvertible, single-series, registered debentures in the amount of R$142,403, maturing on May 20, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On July 20, 2025, São Lucas conducted the tenth private issue of nonconvertible, single-series, registered debentures in the amount of R$20,000, maturing on July 20, 2026; however, this term was extended to July 20, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On December 9, 2025, São Lucas conducted the eleventh private issue of nonconvertible, single-series, registered debentures in the amount of R$450,000, maturing on December 10, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      9. On March 28, 2025, Proncor conducted the tenth private issue of nonconvertible, single-series, registered debentures in the amount of R$5,000, maturing on March 28, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On May 13, 2025, Proncor conducted the eleventh private issue of nonconvertible, single-series, registered debentures in the amount of R$22,690, maturing on May 13, 2026. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value were paid on the maturity date, plus yield. There are no guarantees for the debentures.

        On July 24, 2025, Proncor conducted the twelfth private issue of nonconvertible, single-series, registered debentures in the amount of R$366,600, maturing on July 24, 2026; however, this term was extended to July 26, 2027. As of September 30, 2026, R$293,531 had been subscribed. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or.

        Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      10. On April 17, 2025, Acreditar conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$181,000, initially maturing on April 17, 2026; however, this term was extended to April 20, 2027. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      11. On April 17, 2025, Onco Dor Oncologia conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$235,000, maturing on April 20, 2028. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees for the debentures.

      12. On April 18, 2025, Onco Dor BA Oncologia Ltda. (Cehon) carried out a private placement of book-entry nonconvertible commercial papers, without security interest or collateral security system, in a single series, of second issue, in the amount of R$75,800, maturing on April 20, 2027. The commercial papers may be fully or partially subscribed until the maturity date by Rede D'Or. Commercial notes not subscribed after this period will be automatically canceled. The commercial papers earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.0% p.a. Interest and the nominal value will be paid on the maturity date, plus yield. There are no guarantees.

      13. On August 10, 2025, Oncologia Rede D'Or S.A. conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$370,000, maturing on August 10, 2030. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100%

        of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 4.00% p.a. Interest is paid semiannually, and the nominal value will be paid on the maturity date. There are no guarantees for the debentures.

      14. On August 10, 2025, São Rafael conducted the first private issue of nonconvertible, single-series, registered debentures in the amount of R$270,000, maturing on August 10, 2030. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.75% p.a. Interest is paid semiannually, and the nominal value will be paid on the maturity date. There are no guarantees for the debentures.

      15. On November 24, 2025, SulAmérica Companhia de Seguro Saúde conducted the second private issue of nonconvertible, single-series, registered debentures amounting to R$1,000,000, maturing on November 18, 2033. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 1.10% p.a. Interest is paid semiannually, and the nominal value will be paid on the maturity date. There are no guarantees for the debentures.

      16. On March 16, 2026, Mederi Distribuição e Importação de Produtos para a Saúde S.A. conducted the seventh private issue of nonconvertible, single-series, registered debentures in the amount of R$208,500, maturing on March 20, 2027. Until October 23, 2026, the Company had made early redemptions totaling R$54,395. The debentures may be fully or partially subscribed until the maturity date by Rede D'Or. Debentures not subscribed after this period will be automatically canceled. The debentures earn interest on a pro rata basis equivalent to 100% of the positive percentage variation of the CDI (Interbank Deposit Certificate) plus 2.90% p.a.; however, from October 26, 2026, the additional interest rate was increased to 4.00% p.a. Interest is paid semiannually, and the nominal value will be paid on the maturity date. There are no guarantees for the debentures.

    Key management personnel compensation

    The Company considers "Key management personnel" only the members of its Statutory Board and Board of Directors. At September 30, 2026 and 2025, key management personnel compensation is summarized as follows:

    09/30/2026

    09/30/2025

    Salaries and bonuses

    158,512

    99,329

    Benefits

    372

    291

    Share-based payment

    24,489

    16,689

    183,373

    116,309

  8. Investments

    Breakdown of and changes in investments - Individual

    Equity

    Capital increase/redu

    ction/advance for future

    capital

    Company 12/31/2025

    accounting Dividends

    increase Transfer Other 09/30/2026

    Medise Medicina Diagnóstico e Serviços S.A.

    141,626

    33,955

    (48,812)

    -

    -

    (2,263)

    124,506

    Hospital Esperança S.A.

    4,968,562

    223,984

    (118,064)

    140,808

    -

    -

    5,215,290

    PMJ Empreendimentos Imobiliários S.A. (a)

    925,303

    8,277

    (24,471)

    (27,352)

    (269,572)

    -

    612,185

    Norte D'Or Participações S.A. (including goodwill)

    132,474

    13,422

    -

    266

    -

    -

    146,162

    Onco D'Or Oncologia S.A.

    297,402

    166,583

    -

    -

    -

    (6,550)

    457,435

    Jenner S.A. (including goodwill)

    68,836

    69,329

    -

    -

    -

    (8,168)

    129,997

    JMJB Diagnósticos e Serviços Hospitalares

    43,731

    (5,181)

    -

    -

    -

    -

    38,550

    Hospital Fluminense S.A. (including goodwill)

    348,315

    65,116

    (59,239)

    (72,020)

    -

    -

    282,172

    Cardial Serviços Médicos (including goodwill)

    177,515

    57,937

    (42,000)

    -

    -

    1,310

    194,762

    TJK Empreendimentos Hospitalares

    17,953

    1,541

    (2,491)

    -

    -

    -

    17,003

    Santa Luzia II Empreendimentos Imobiliários Ltda.

    60,114

    (733)

    -

    (13,122)

    -

    -

    46,259

    Clínica São Vicente (a)/(b)

    4,208,667

    222,465

    (156,083)

    49,698

    (108,386)

    750,675

    4,967,036

    Rede D'or São Luiz Serviços Médicos S.A.

    262,279

    (44,938)

    -

    87,732

    (5,612)

    -

    299,461

    Laboratórios Richet

    379,059

    (28,227)

    -

    71,830

    -

    9,514

    432,176

    Qualicorp Consultoria e Corretora de Seguros S.A.

    485,090

    848

    -

    -

    -

    (242)

    485,696

    Clínica Médica São Remo

    66,817

    (4,912)

    -

    13,243

    -

    -

    75,148

    Hospital Santa Cruz

    445,481

    23,298

    (6,337)

    1,375

    -

    -

    461,067

    Advance Plano de Saúde S.A.

    31,323

    2,581

    -

    -

    -

    -

    33,904

    PrismaQuali Gestão Ativa de Participações S.A.

    1,607,280

    3,076

    -

    (4,657)

    -

    (1,322)

    1,604,377

    RDSLGF Greenfields Ltda.

    915,759

    39,961

    (460)

    5,675

    147,888

    18,006

    1,126,829

    RDSL OH Operações Hospitalares Ltda.

    286,305

    100,189

    (5,040)

    104,923

    63,797

    2,916

    553,090

    Traditio Companhia de Seguros

    5,862,361

    965,985

    (203,152)

    -

    -

    44,020

    6,669,214

    Cia Saúde - SulAmérica

    5,245,987

    1,170,018

    (276,000)

    -

    -

    55,067

    6,195,072

    SAEPAR Serviços e Participações

    2,547,373

    412,376

    (76,900)

    -

    -

    16,138

    2,898,987

    Other

    1,942,636

    10,997

    (100,943)

    137,587

    (38,560)

    8,510

    1,960,227

    31,468,248 3,507,947 (1,119,992) 493,236 (210,445) 887,611 35,026,605

    1. On January 30, 2026, the Company completed the contribution of the assets and liabilities of Hospital Glória D'Or and SPE IH Glória D'Or to Atlântica D'Or.

    2. On June 17, 2026, Clínica São Vicente, through its wholly-owned subsidiary Clínica São Lucas, acquired all shares in Biocor held by noncontrolling shareholders, representing 49% of the total shares, for R$129,200. The Company recognized a put/call option in financial liabilities amounting to R$495,211 at the exercise date. Accordingly, the liability was fully derecognized, resulting in an effect of R$366,011 arising from a capital transaction, recognized against equity attributable to noncontrolling shareholders. In addition, the amount recognized as noncontrolling interests in the consolidated financial statements, measured at fair value upon acquisition of control, was also added to the investment held by the parent company, with a corresponding entry to capital reserve, totaling R$750,675, with a corresponding entry recognized directly in equity, with no impact on profit or los s for the period (and no change in consolidated goodwill).

    Capital

    increase/advanc

    Company 12/31/2025

    Equity accounting

    e for future

    capital increase 09/30/2026

    Onco Star

    (596,939)

    (96,314)

    -

    (693,253)

    Centro Hospitalar São Marcos S.A.

    (5,895)

    (97)

    139

    (5,853)

    Hospital São Marcos (including goodwill)

    (69,889)

    (227)

    -

    (70,116)

    Rede D'Or Finance

    (166,598) 5,785 - (160,813)

    (839,321) (90,853) 139 (930,035)

    Equity accounting

    3,417,094

    Company 12/31/2024

    Equity

    accounting Dividends

    Capital

    increase/reduction/ advance for future capital increase

    Trans fers to assets held

    for sale Trans fers Write-offs Other 09/30/2025

    Medise Medicina Diagnóstico e Serviços S.A.

    139,584

    22,014

    -

    (29,146)

    -

    -

    -

    673

    133,125

    Hospital Esperança S.A.

    5,175,670

    258,626

    (458,110)

    (46,503)

    -

    (1,000)

    -

    -

    4,928,683

    PMJ Empreendimentos Imobiliários S.A.

    889,825

    15,738

    (15,265)

    26,397

    -

    (14,398)

    -

    -

    902,297

    Norte D'Or Participações S.A. (including goodwill)

    133,602

    (3,215)

    -

    510

    -

    -

    -

    -

    130,897

    Onco D'Or Oncologia S.A.

    1,096,859

    182,525

    (895,593)

    -

    -

    -

    -

    23,554

    407,345

    Jenner S.A. (including goodwill)

    369,301

    82,601

    (346,276)

    -

    -

    -

    -

    -

    105,626

    JMJB Diagnósticos e Serviços Hospitalares

    44,811

    (2,254)

    -

    -

    -

    -

    -

    -

    42,557

    Rodin Empreendimentos e Participações S.A.

    447,492

    (12,527)

    -

    30,553

    -

    -

    (465,518)

    -

    -

    Quinta Empreendimentos Imobiliários Ltda.

    84,724

    12,601

    (16,482)

    -

    -

    (22,918)

    (57,925)

    -

    -

    Hospital Fluminense S.A. (including goodwill)

    317,729

    32,548

    (29,289)

    3,525

    -

    -

    -

    -

    324,513

    Cardial Serviços Médicos (including goodwill)

    137,980

    49,692

    (25,620)

    -

    -

    -

    -

    -

    162,052

    TJK Empreendimentos Hospitalares

    17,513

    1,829

    (1,950)

    -

    -

    -

    -

    -

    17,392

    Villa Lobos Empreendimentos Imobiliários Ltda.

    173,630

    15,426

    (1,770)

    -

    -

    (34,322)

    (152,964)

    -

    -

    Santa Luzia II Empreendimentos Imobiliários Ltda.

    61,572

    (1,340)

    -

    -

    -

    -

    -

    -

    60,232

    Campinas Empreendimentos Imobiliários Ltda.

    364,359

    4,066

    -

    -

    -

    (363,197)

    -

    (5,228)

    -

    Sator Empreendimentos e Participações Ltda.

    4,089,079

    186,724

    (78,181)

    (275,883)

    -

    -

    -

    -

    3,921,739

    Rede D'or São Luiz Serviços Médicos S.A.

    415,271

    (11,792)

    (76,673)

    (85,141)

    -

    -

    -

    -

    241,665

    Olimpia Projeto Rua do Rocio 86 SPE S.A.

    623,100

    22,224

    (3,504)

    (37,421)

    -

    (31,037)

    -

    -

    573,362

    Laboratórios Richet

    361,915

    (8,839)

    -

    16,840

    -

    -

    -

    -

    369,916

    Santa Luzia III

    306,751

    16,728

    -

    5,513

    -

    (15,183)

    (313,809)

    -

    -

    Qualicorp Consultoria e Corretora de Seguros S.A.

    484,640

    (132)

    (94)

    -

    -

    -

    -

    (2)

    484,412

    Clínica Médica São Remo

    58,453

    (6,759)

    -

    11,269

    -

    -

    -

    -

    62,963

    Hospital Santa Cruz

    433,842

    20,495

    (49,347)

    17,082

    -

    -

    -

    -

    422,072

    Advance Plano de Saúde S.A.

    40,419

    (6,156)

    -

    -

    -

    -

    -

    -

    34,263

    Prisma Capital

    1,604,880

    (97)

    -

    -

    -

    -

    -

    -

    1,604,783

    RDSLGF Greenfields Ltda.

    540,958

    17,907

    -

    (13,652)

    -

    363,197

    -

    -

    908,410

    RDSL OH Operações Hospitalares Ltda.

    114,943

    72,652

    -

    128,451

    -

    -

    -

    -

    316,046

    Traditio Companhia de Seguros

    5,002,876

    867,903

    -

    136,641

    -

    -

    -

    (49,693)

    5,957,727

    Cia Saúde - SulAmérica

    4,183,579

    1,059,422

    (211,439)

    203,101

    -

    -

    -

    (51,849)

    5,182,814

    SAEPAR Serviços e Participações

    2,183,881

    373,931

    -

    62,715

    -

    -

    -

    (39,480)

    2,581,047

    Other

    1,779,914

    106,837

    (86,781)

    427,967

    (225,005)

    118,858

    (235,481)

    33,990

    1,920,299

    31,679,152

    3,369,378

    (2,296,374)

    582,818

    (225,005)

    -

    (1,225,697)

    (88,035)

    31,796,237

    Company 12/31/2024

    Equity accounting

    Capital

    increase/reduction/ advance for future

    capital increase Other 09/30/2025

    Onco Star

    (454,758)

    (99,986)

    -

    (5,966)

    (560,710)

    Centro Hospitalar São Marcos S.A.

    (8,911)

    51

    15

    -

    (8,845)

    Hospital São Marcos (including goodwill)

    (97,039)

    (28,381)

    (4,904)

    (4,743)

    (135,067)

    Rede D'Or Finance

    (158,713) (2,599) - - (161,312)

    (719,421) (130,915) (4,889) 10,709) (865,934)

    Equity accounting

    3,238,463

    Breakdown of and changes in investments - Consolidated

    Capital

    increase/adva nce for future

    Company

    12/31/2025

    Equity accounting

    Dividends

    capital increase

    Other

    09/30/2026

    JMJB Diagnósticos e Serviços Hospitalares S.A.

    43,731

    (5,181)

    -

    -

    -

    38,550

    Instituto de Radioterapia do Vale do Paraíba Ltda.

    17,194

    552

    -

    -

    (206)

    17,540

    Qualicorp Consultoria e Corretora de Seguros S.A. (a)

    2,089,212

    3,652

    -

    -

    (1,041)

    2,091,823

    Eldorado do Sul Participações Ltda.

    10,707

    5,777

    (1,955)

    -

    (681)

    13,848

    Other

    277,020

    22,999

    (12,062)

    32,054

    649

    320,660

    2,437,864

    27,799

    (14,017)

    32,054

    (1,279)

    2,482,421

    Equity

    Acquisition of

    Company 12/31/2024

    accounting

    control

    Dividends

    Other

    Transfer

    09/30/2025

    JMJB Diagnósticos e Serviços Hospitalares S.A.

    44,811

    (2,254)

    -

    -

    -

    -

    42,557

    Instituto de Radioterapia do Vale do Paraíba Ltda.

    16,686

    661

    -

    -

    (250)

    -

    17,097

    Qualicorp Consultoria e Corretora de Seguros S.A. (a)

    2,087,272

    (568)

    -

    (404)

    (9)

    -

    2,086,291

    Eldorado do Sul Participações Ltda.

    35,791

    6,883

    -

    (28,853)

    (47)

    -

    13,774

    Other

    298,996

    24,077

    1,666

    (15,814)

    -

    (17,471)

    291,454

    2,483,556

    28,799

    1,666

    (45,071)

    (306)

    (17,471)

    2,451,173

    1. Based on the shareholders' agreement entered into in November 2019, considering the nominations to the Executive Board and Board of Directors that the Company is entitled to, it was concluded that Rede D'Or has significant influence over Qualicorp; therefore, it records the investment using the equity method. The Company recognized the equity accounting through June 30, 2026, in accordance with IAS 28 (CPC 18) - Investments in Associates and Joint Ventures.

    Summary of information on main subsidiaries

    09/30/2026 09/30/2025

    Operating

    Profit or

    Profit or

    % Total

    % Voting

    capital

    Assets

    Liabilities

    Equity

    income

    (expenses)

    los s for the

    period

    los s for the

    period

    Direct and indirect subsidiaries

    Medise Medicina Diagnóstico e Serviços S.A. ("Medise")

    100.00

    100.00

    382,198

    258,600

    123,598

    54,548

    37,803

    24,509

    Hospital Esperança S.A. ("Esperança")

    100.00

    100.00

    11,864,991

    5,305,729

    6,559,262

    487,895

    224,208

    230,504

    PMJ Empreendimentos Imobiliários S.A.

    100.00

    100.00

    870,561

    245,052

    625,509

    9,781

    8,285

    15,753

    Norte D'Or Participações S.A.

    100.00

    100.00

    117,755

    5

    117,750

    13,254

    13,435

    (3,218)

    Onco D'Or Oncologia S.A.

    98.87

    98.87

    916,105

    446,374

    469,731

    200,473

    173,091

    187,513

    Jenner S.A.

    91.24

    91.24

    170,741

    24

    170,717

    138,535

    138,657

    150,730

    JMJB Diagnósticos e Serviços Hospitalares S.A.

    50.00

    50.00

    87,507

    9,787

    77,720

    (10,362)

    (5,181)

    (2,254)

    Hospital Fluminense S.A.

    100.00

    100.00

    550,860

    281,919

    268,941

    97,225

    65,181

    32,581

    Cardial Serviços Médicos Ltda.

    89.44

    89.44

    261,767

    97,549

    164,218

    94,224

    57,937

    49,692

    TJK Empreendimentos Imobiliários Ltda.

    100.00

    100.00

    17,232

    218

    17,014

    1,653

    1,541

    1,829

    Santa Luzia II Emp. Imobiliários Ltda.

    100.00

    100.00

    47,540

    1,232

    46,308

    (1,571)

    (733)

    (1,340)

    Clínica São Vicente

    100.00

    100.00

    7,849,357

    2,542,044

    5,307,313

    297,758

    222,465

    172,232

    Rede D'Or Finance

    100.00

    100.00

    12,191,804

    12,352,617

    (160,813)

    (775)

    5,785

    (2,599)

    Rede D'Or São Luiz Serviços Médicos S.A.

    100.00

    100.00

    489,080

    189,343

    299,737

    (70,627)

    (44,942)

    (11,793)

    Laboratórios Richet

    100.00

    100.00

    635,818

    150,241

    485,577

    (23,611)

    (28,255)

    (8,847)

    Onco Star SP Oncologia Ltda.

    84.00

    84.00

    1,617,242

    2,443,278

    (826,036)

    19,254

    (96,314)

    (99,986)

    Centro Hospitalar São Marcos S.A

    100.00

    100.00

    20

    540

    (520)

    (97)

    (97)

    51

    Hospital São Marcos

    100.00

    100.00

    324,934

    406,098

    (81,164)

    2,184

    (227)

    (28,410)

    Clínica Médica São Remo

    100.00

    100.00

    95,314

    22,208

    73,106

    (3,825)

    (4,912)

    (6,760)

    Hospital Santa Cruz

    100.00

    100.00

    1,062,535

    298,034

    764,501

    57,511

    35,306

    31,058

    Advance Plano de Saúde S.A.

    100.00

    100.00

    47,210

    12,688

    34,522

    (49)

    2,581

    (6,157)

    PrismaQuali Gestão Ativa de Participações S.A.

    100.00

    100.00

    1,607,345

    -

    1,607,345

    2,804

    3,079

    (97)

    RDSLGF Greenfields Ltda.

    100.00

    100.00

    1,129,432

    23

    1,129,409

    39,815

    39,961

    17,907

    RDSL OH Operações Hospitalares Ltda.

    100.00

    100.00

    553,128

    35

    553,093

    99,969

    100,189

    72,652

    Traditio Companhia de Seguros

    100.00

    100.00

    9,691,491

    237,091

    9,454,400

    1,324,662

    1,369,415

    1,214,226

    Cia Saúde - SulAmérica

    100.00

    100.00

    32,954,559

    19,489,279

    13,465,280

    3,312,097

    2,543,517

    2,261,009

    SAEPAR Serviços e participações

    100.00

    100.00

    3,014,424

    115,437

    2,898,987

    417,925

    412,376

    373,931

    Summary of the associates' and joint ventures' information

    09/30/2026 09/30/2025

    Profit or

    % Total

    ompanies recognized under the equity method in the consolidated financial statements

    JMJB Diagnósticos e Serviços Hospitalares S.A.

    50.00

    50.00

    87,504

    9,786

    77,718

    (10,362)

    (5,181)

    (2,254)

    Instituto de Radioterapia do Vale do Paraíba Ltda.

    50.00

    50.00

    13,352

    1,088

    12,264

    1,463

    552

    14.571

    Eldorado do Sul Participações Ltda.

    33.33

    33.33

    21,340

    5,867

    15,473

    17,332

    5,777

    6,883

    Qualicorp Consultoria e Corretora de Seguros S.A. (a)

    25.85

    25.85

    3,431,058

    2,077,419

    1,353,639

    (a)

    (a)

    (b)

    C

    % Voting

    capital Assets Liabilities

    .

    Equity

    Operating

    income (expenses)

    loss

    for the period

    Profit or loss for the period

    1. The Company recognized the equity accounting until June 30, 2026.

    2. The Company recognized the equity accounting until June 30, 2025.

    Impairment

    The recoverable amount of a CGU is determined based on the calculation of value in use. These calculations use cash flow projections based on financial budgets approved by management covering a five- to seven-year period. Assumptions are described in Note 10.

    There is no indication of impairment of investments to date.

  9. Property and equipment

    Balance breakdown

    Individual

    09/30/2026 12/31/2025

    Description

    Depreciation

    rate Cost

    Accumulated depreciation

    Net

    value Cost

    Accumulated depreciation

    Net value

    Hospital machinery and equipment

    12% to 20%

    2,122,645

    (1,610,403)

    512,242

    2,079,259

    (1,566,315)

    512,944

    Surgical instruments

    20%

    150,704

    (106,284)

    44,420

    160,996

    (103,456)

    57,540

    Machinery and equipment

    7% to 10%

    1,208,597

    (801,345)

    407,252

    1,149,655

    (741,717)

    407,938

    Buildings

    2.5% to 4%

    893,776

    (373,466)

    520,310

    968,848

    (346,391)

    622,457

    Improvements in own buildings

    4%

    512,390

    (223,567)

    288,823

    510,977

    (209,161)

    301,816

    Leasehold improvements

    3% to 4%

    4,595,877

    (1,046,903)

    3,548,974

    3,991,708

    (915,466)

    3,076,242

    Furniture and fixtures

    10%

    317,117

    (261,166)

    55,951

    307,366

    (245,411)

    61,955

    Vehicles

    20%

    6,364

    (5,182)

    1,182

    5,907

    (4,965)

    942

    Facilities

    10%

    226,853

    (132,428)

    94,425

    217,166

    (119,897)

    97,269

    Land

    -

    147,698

    -

    147,698

    147,698

    -

    147,698

    Construction in progress

    -

    1,061,516

    -

    1,061,516

    921,005

    -

    921,005

    Other

    5% to 10%

    15,183

    (8,128)

    7,055

    15,295

    (7,862)

    7,433

    11,258,720

    (4,568,872)

    6,689,848

    10,475,880

    (4,260,641)

    6,215,239

    Consolidated

    09/30/2026

    12/31/2025

    Depreciation

    Accumulated

    Net

    Accumulated

    Net

    Description

    rate

    Cost

    depreciation

    value

    Cost

    depreciation

    value

    Hospital machinery and equipment

    12% to 20%

    4,499,955

    (3,069,802)

    1,430,153

    4,255,122

    (2,807,142)

    1,447,980

    Surgical instruments

    20%

    409,498

    (255,274)

    154,224

    384,211

    (228,297)

    155,914

    Machinery and equipment

    7% to 10%

    2,002,528

    (1,281,220)

    721,308

    1,876,669

    (1,181,256)

    695,413

    Buildings

    2.5% to 4%

    5,952,866

    (1,265,441)

    4,687,425

    5,887,248

    (1,084,168)

    4,803,080

    Improvements in own buildings

    4%

    1,226,423

    (345,211)

    881,212

    1,056,420

    (310,001)

    746,419

    Leasehold improvements

    3% to 4%

    7,609,233

    (1,571,518)

    6,037,715

    6,530,521

    (1,356,330)

    5,174,191

    Furniture and fixtures

    10%

    617,869

    (445,828)

    172,041

    581,154

    (412,023)

    169,131

    Vehicles

    20%

    30,860

    (27,987)

    2,873

    30,104

    (27,303)

    2,801

    Facilities

    10%

    529,162

    (264,089)

    265,073

    509,626

    (237,609)

    272,017

    Land

    -

    1,315,565

    -

    1,315,565

    1,304,085

    -

    1,304,085

    Construction in progress

    -

    2,482,611

    -

    2,482,611

    1,967,776

    -

    1,967,776

    Other

    5% to 10%

    63,812

    (12,955)

    50,857

    62,922

    (11,799)

    51,123

    26,740,382

    (8,539,325)

    18,201,057

    24,445,858

    (7,655,928)

    16,789,930

    Changes - Individual

    12/31/2025

    Additions

    Transfers (a)

    09/30/2026

    Cost

    Hospital machinery and equipment

    2,079,259

    102,102

    (58,716)

    2,122,645

    Surgical instruments

    160,996

    11,559

    (21,851)

    150,704

    Machinery and equipment

    1,149,655

    69,912

    (10,970)

    1,208,597

    Buildings

    968,848

    46

    (75,118)

    893,776

    Improvements in own buildings

    510,977

    811

    602

    512,390

    Leasehold improvements

    3,991,708

    326,473

    277,696

    4,595,877

    Furniture and fixtures

    307,366

    14,646

    (4,895)

    317,117

    Vehicles

    5,907

    457

    -

    6,364

    Facilities

    217,166

    11,389

    (1,702)

    226,853

    Land

    147,698

    -

    -

    147,698

    Construction in progress

    921,005

    434,806

    (294,295)

    1,061,516

    Other

    15,295

    50

    (162)

    15,183

    10,475,880

    972,251

    (189,411)

    11,258,720

    Depreciation

    Hospital machinery and equipment

    (1,566,315)

    (80,862)

    36,774

    (1,610,403)

    Surgical instruments

    (103,456)

    (10,809)

    7,981

    (106,284)

    Machinery and equipment

    (741,717)

    (65,859)

    6,231

    (801,345)

    Buildings

    (346,391)

    (28,327)

    1,252

    (373,466)

    Improvements in own buildings

    (209,161)

    (14,406)

    -

    (223,567)

    Leasehold improvements

    (915,466)

    (133,858)

    2,421

    (1,046,903)

    Furniture and fixtures

    (245,411)

    (17,317)

    1,562

    (261,166)

    Vehicles

    (4,965)

    (217)

    -

    (5,182)

    Facilities

    (119,897)

    (12,805)

    274

    (132,428)

    Other

    (7,862)

    (298)

    32

    (8,128)

    (4,260,641)

    (364,758)

    56,527

    (4,568,872)

    Property and equipment, net

    6,215,239

    607,493

    (132,884)

    6,689,848

    1. The effect of R$132,884 relates to the transfer of assets of Hospital São Luiz Maternidade Star from the parent company to "Atlântica D'Or".

    12/31/2024

    Additions

    Transfers (a)

    09/30/2025

    Cost

    Hospital machinery and equipment

    1,843,976

    227,112

    (57,922)

    2,013,166

    Surgical instruments

    146,112

    9,569

    (1,183)

    154,498

    Machinery and equipment

    1,057,171

    52,184

    (6,067)

    1,103,288

    Buildings

    892,674

    1,037

    -

    893,711

    Improvements in own buildings

    488,456

    12,764

    7,972

    509,192

    Leasehold improvements

    3,382,389

    220,791

    76,479

    3,679,659

    Furniture and fixtures

    279,474

    17,814

    (807)

    296,481

    Vehicles

    5,907

    -

    -

    5,907

    Facilities

    170,881

    33,856

    (64)

    204,673

    Land

    147,698

    -

    -

    147,698

    Construction in progress

    1,097,248

    122,807

    (95,262)

    1,124,793

    Other

    14,800

    395

    (5)

    15,190

    9,526,786

    698,329

    (76,859)

    10,148,256

    Depreciation

    Hospital machinery and equipment

    (1,473,756)

    (121,996)

    17,894

    (1,577,858)

    Surgical instruments

    (86,720)

    (12,645)

    386

    (98,979)

    Machinery and equipment

    (650,215)

    (84,505)

    653

    (734,067)

    Buildings

    (308,517)

    (27,841)

    -

    (336,358)

    Improvements in own buildings

    (190,572)

    (13,790)

    -

    (204,362)

    Leasehold improvements

    (769,766)

    (105,827)

    30

    (875,563)

    Furniture and fixtures

    (218,689)

    (19,914)

    112

    (238,491)

    Vehicles

    (4,812)

    (98)

    -

    (4,910)

    Facilities

    (103,611)

    (11,708)

    6

    (115,313)

    Other

    (7,348)

    (374)

    -

    (7,722)

    (3,814,006)

    (398,698)

    19,081

    (4,193,623)

    Property and equipment, net

    5,712,780

    299,631

    (57,778)

    5,954,633

    1. The effect of R$57,778 relates to the transfer of assets of Hospital São Luiz Campinas from the parent company to "Atlântica D'Or".

      Changes - Consolidated

      12/31/2025

      Additions

      Transfers

      09/30/2026

      Cost

      Hospital machinery and equipment

      4,255,122

      244,833

      -

      4,499,955

      Surgical instruments

      384,211

      25,287

      -

      409,498

      Machinery and equipment

      1,876,669

      125,859

      -

      2,002,528

      Buildings

      5,887,248

      65,618

      -

      5,952,866

      Improvements in own buildings

      1,056,420

      98,490

      71,513

      1,226,423

      Leasehold improvements

      6,530,521

      521,305

      557,407

      7,609,233

      Furniture and fixtures

      581,154

      36,715

      -

      617,869

      Vehicles

      30,104

      756

      -

      30,860

      Facilities

      509,626

      19,536

      -

      529,162

      Land

      1,304,085

      11,480

      -

      1,315,565

      Construction in progress

      1,967,776

      1,143,755

      (628,920)

      2,482,611

      Other

      62,922

      890

      -

      63,812

      24,445,858

      2,294,524

      -

      26,740,382

      Depreciation

      Hospital machinery and equipment

      (2,807,142)

      (262,660)

      -

      (3,069,802)

      Surgical instruments

      (228,297)

      (26,977)

      -

      (255,274)

      Machinery and equipment

      (1,181,256)

      (99,964)

      -

      (1,281,220)

      Buildings

      (1,084,168)

      (181,273)

      -

      (1,265,441)

      Improvements in own buildings

      (310,001)

      (35,210)

      -

      (345,211)

      Leasehold improvements

      (1,356,330)

      (215,188)

      -

      (1,571,518)

      Furniture and fixtures

      (412,023)

      (33,805)

      -

      (445,828)

      Vehicles

      (27,303)

      (684)

      -

      (27,987)

      Facilities

      (237,609)

      (26,480)

      -

      (264,089)

      Other

      (11,799)

      (1,156)

      -

      (12,955)

      (7,655,928)

      (883,397)

      -

      (8,539,325)

      Property and equipment, net

      16,789,930

      1,411,127

      -

      18,201,057

      12/31/2024

      Additions

      Transfers

      Transfers to as sets held for sale

      09/30/2025

      Cost

      Hospital machinery and equipment

      3,710,404

      445,445

      -

      (29,131)

      4,126,718

      Surgical instruments

      341,803

      29,695

      -

      -

      371,498

      Machinery and equipment

      1,631,824

      195,104

      -

      (103,057)

      1,723,871

      Buildings

      4,773,617

      792,056

      294,124

      -

      5,859,797

      Improvements in own buildings

      854,783

      70,623

      83,732

      -

      1,009,138

      Leasehold improvements

      5,251,827

      378,954

      402,808

      (44,717)

      5,988,872

      Furniture and fixtures

      548,445

      29,873

      -

      (10,470)

      567,848

      Vehicles

      30,666

      -

      -

      (1,387)

      29,279

      Facilities

      455,622

      70,778

      -

      (60,595)

      465,805

      Land

      1,270,421

      20,899

      -

      (3,342)

      1,287,978

      Construction in progress

      2,590,389

      397,334

      (780,664)

      (4,611)

      2,202,448

      Other

      61,736

      1,043

      -

      (3,904)

      58,875

      21,521,537

      2,431,804

      -

      (261,214)

      23,692,127

      Depreciation

      Hospital machinery and equipment

      (2,470,553)

      (284,838)

      -

      13,524

      (2,741,867)

      Surgical instruments

      (188,909)

      (28,448)

      -

      -

      (217,357)

      Machinery and equipment

      (1,018,232)

      (135,466)

      -

      47,924

      (1,105,774)

      Buildings

      (862,555)

      (159,265)

      -

      -

      (1,021,820)

      Improvements in own buildings

      (265,916)

      (33,132)

      -

      -

      (299,048)

      Leasehold improvements

      (1,129,152)

      (165,889)

      -

      23,751

      (1,271,290)

      Furniture and fixtures

      (366,340)

      (34,274)

      -

      6,608

      (394,006)

      Vehicles

      (26,822)

      (288)

      -

      1,378

      (25,732)

      Facilities

      (204,747)

      (25,997)

      -

      13,518

      (217,226)

      Other

      (9,853)

      (1,655)

      -

      2,176

      (9,332)

      (6,543,079)

      (869,252)

      -

      108,879

      (7,303,452)

      Property and equipment, net

      14,978,458

      1,562,552

      -

      (152,335)

      16,388,675

      Significant changes for the periods ended September 30, 2026 and 2025 were as follows: 2026

      1. Investments in the expansion works of hospital facilities such as Hospital Itaim and Hospital Caxias D'Or, as well as the new towers of Hospitals Santa Luzia Star, UDI, and São Lucas.

      2. Capital expenditures on improvements aimed at the expansion and growth of hospitals, primarily São Lucas, Central Tatuapé, and Morumbi.

      3. Purchases of medical and hospital machinery and equipment for Hospitals DF Star, Vila Nova Star, Caxias D'Or, Oeste D'Or and Anália, as well as for the Atlântica D'Or Complex.

      4. Investments in construction works of Hospitals Ribeirão Preto, Sorocaba and Taubaté.

    2025

    1. Investments in the expansion works of hospital facilities such as Hospital Assunção, São Vicente, Onco Star and the new tower of UDI Hospital.

    2. Expenses with improvements for the growth and expansion of hospitals and clinics, primarily Hospitals São Lucas, Assunção, Morumbi, and UDI.

    3. Purchases of hospital machinery and equipment for the Hospitals new Barra D'Or, Anália, Hospital Assunção, Onco Star, Aliança, and São Vicente.

    4. Investments in construction works of Hospitals Taubaté and Ribeirão Preto.

    Capitalized borrowing costs

    The Company capitalizes borrowing costs attributable to qualifying assets. At September 30, 2026, R$99,092 (R$128,827 at September 30, 2025) in interest on loans and financing were capitalized in Property and equipment.

    Impairment testing of property and equipment

    Management has assessed the existence of events or changes in economic, operational or technological circumstances and has not identified any evidence that could indicate deterioration or impairment of property and equipment.

  10. Intangible ass ets

Annual Individual Consolidated

amortization rate

09/30/2026

12/31/2025

09/30/2026

12/31/2025

Finite useful life Software

20%

300,679

324,987

772,753

802,283

Customer portfolio - SASA

11% to 20%

73,189

100,077

73,189

100,077

Exclusive agreements

20%

11,579

14,727

92,712

102,950

Other

-

-

3,155

5,920

Indefinite useful life Goodwill

Acquisition of Copa D'Or

80,058

80,058

80,058

80,058

Acquisition of HMSL

668,339

668,339

668,339

668,339

Acquisition of Hospital Brasil

121,398

121,398

121,398

121,398

Acquisition of Hospital Prontolinda

30,595

30,595

30,595

30,595

Acquisition of Vivalle

38,692

38,692

38,692

38,692

Acquisition of São Marcos

-

-

10,807

10,807

Acquisition of Santa Luzia

199,333

199,333

199,333

199,333

Acquisition of Sinisgalli

156,646

156,646

156,646

156,646

Acquisition of Hospital Esperança

-

-

108,408

108,408

Acquisition of Norte D'Or

-

-

28,450

28,450

Acquisition of IFOR

85,724

85,724

85,724

85,724

Acquisition of Sino Brasileiro

241,947

241,947

241,947

241,947

Acquisition of Villa-Lobos

136,074

136,074

136,074

136,074

Acquisition of Bartira

105,584

105,584

105,584

105,584

Acquisition of Onco ABC/Cardeal/JLD

-

-

55,414

55,414

Acquisition of Oncoholding

-

-

159,445

159,445

Acquisition of Hospital Fluminense

-

-

10,658

10,658

Acquisition of Hospital Santa Helena

125,802

125,802

125,802

125,802

Acquisition of Acreditar

-

-

155,720

155,720

Acquisition of Memorial São Jose

112,528

112,528

112,528

112,528

Acquisition of Alpha-Med

-

-

43,815

43,815

Acquisition of CEHON

-

-

68,757

68,757

Acquisition of Maximagem

46,742

46,742

46,742

46,742

Acquisition of Ribeirão Pires

129,739

129,739

129,739

129,739

Acquisition of NEOH

-

-

33,422

33,422

Acquisition of Salus

-

-

8,956

8,956

Acquisition of Prontimagem

-

-

6,220

6,220

Acquisition of Sator

-

-

163,089

163,089

Acquisition of Hospital São Rafael

-

-

509,363

509,363

Acquisition of Laboratório Richet

-

-

184,232

184,232

Acquisition of UDI

-

-

335,883

335,883

Acquisition of Samer

-

-

70,939

70,939

Acquisition of Hospital Rio Mar

-

-

94,833

94,833

Acquisition of Hospital São Lucas

-

-

223,079

223,079

Acquisition of Hospital Aviccena

60,476

60,476

60,476

60,476

Acquisition of Perinatal

655,580

655,580

655,580

655,580

Acquisition of Hospital Santa Cruz

-

-

299,583

299,583

Acquisition of Aliança

-

-

925,555

925,555

Acquisition of Salute

-

-

15,475

15,475

Acquisition of São Carlos

-

-

160,139

160,139

Acquisition of Clínica São Lucas

-

-

45,673

45,673

Acquisition of Clivalle

-

-

40,786

40,786

Acquisition of HCP/Cárdio Pulmonar

-

-

146,894

146,894

Acquisition of Guaianases

-

-

115,751

115,751

Acquisition of Antônio Afonso

-

-

16,782

16,782

Acquisition of Balbino

-

-

77,500

77,500

Acquisition of América

-

-

456,511

456,511

Acquisition of Serra Mayor

-

-

68,981

68,981

Acquisition of Biocor

-

-

561,269

620,347

Acquisition of Proncor

-

-

202,929

202,929

Acquisition of Santa Emilia

-

-

121,991

121,991

Acquisition of Hospital Nossa Senhora das Neves

-

-

326,634

326,634

Acquisition of HNSN Empreendimentos

-

-

34,790

34,790

Acquisition of Orthoservice

-

-

33,705

33,705

Acquisition of HNA Emp. E Participações

-

-

12,401

12,401

Acquisition of Hospital Novo Atibaia

-

-

173,020

173,020

Acquisition of Hospital Arthur Ramos

-

-

272,686

272,686

Acquisition of Hospital Santa Isabel

-

-

243,287

243,287

Acquisition of Hospital Aeroporto

-

-

171,511

171,511

Acquisition of Paraná Clínicas

-

-

284,701

284,701

Acquisition of Sompo Saúde

-

-

199,384

199,384

Acquisition of Prodent

-

-

106,681

106,681

Acquisition of SASA

1,820,625

1,820,625

1,820,625

1,820,625

Other goodwill

48,650

48,650

294,096

277,329

Trademark - SASA

2,068,575

2,068,575

2,068,575

2,068,575

Trademarks and patents (a) 190,810 190,810 190,986 190,816

7,509,364 7,563,708 15,697,457 15,809,019

(a) This mainly refers to the Hospital São Luiz trademark registered upon its acquisition in 2010.

Software development costs and licenses

These refer mainly to expenditures incurred with the development of technological infrastructure, applications, improvements in the companies' website and in operations of Sul América S.A., development of own systems, and acquisition of software licenses used in operations.

Impairment

Goodwill is allocated to the Cash-Generating Units (CGU) identified by management, i.e. each hospital, as shown in the table above.

The recoverable amount of a CGU is determined based on the calculation of value in use. Value in use calculations use cash flow projections based on financial budgets approved by

management covering a five-year period.

Discount rates represent the current market assessment of the risks specific to each CGU, taking into consideration the time value of money and individual risks of the underlying assets that have not been incorporated in the cash flow estimates. The discount rate calculation is based on the specific circumstances of the Company and is derived from its weighted average cost of capital (WACC). The WACC takes into consideration both debt and equity. The cost of equity is derived from the expected return on investment by the investors. The cost of debt is based on the interest-bearing financing the Company is obliged to service. Segment-specific risk is incorporated by applying individual beta factors. The beta factors are evaluated annually based on publicly available market data.

There is no indication of impairment of intangible assets to date.

Rede D'Or Sao Luiz SA on 6ix

Story so far

Earlier from Rede D'Or Sao Luiz

All Rede D'Or Sao Luiz news releases